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MOLECULAR MECHANISM OF AUTOPHAGY-BASED
UNCONVENTIONAL SECRETION OF IL-1β
By
Shanya Jiang

B.S., Biological Engineering (Medical), Jilin University, China, 2009

ABSTRACT
Proteins without signal peptides can still be released into extracellular space via
ER/Golgi-independent unconventional secretory pathway(s) that remain to be revealed. A
class of leaderless proteins including the pro-inflammatory cytokine interleukin-1β (IL1β) is processed in the cytosol by proteolytic machineries such as the inflammasome
prior to secretion. Studies in yeast uncovered a new unconventional secretory pathway
that is dependent on GRASP (Golgi Reassembly and Stacking Protein) and autophagy
proteins. The purpose of this work was to determine whether this autophagy-based
unconventional secretory pathway (secretory autophagy) is conserved in mammals, how
this secretory autophagy differs from the traditional degradative autophagy, and how
GRASP intersects with the autophagy pathways. Here, we provide the first evidence that
autophagy mediates unconventional secretion of IL-1β in an inflammasome, GRASP55,
and Rab8-dependent manner in mouse bone marrow-derived macrophages, a route which
also applies to IL-18 and non-inflammasome substrate HMGB1. GRASP55 was also
found to be mediating autophagosome formation possibly making secretory
autophagosomes. We also give initial insights to the divergence between degradative
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autophagy and this secretory autophagy pathway, which preferentially utilizes some of
the autophagy-related proteins, LC3A, GABARAP, and p62, but not LC3B, NBR1,
TBK1, and ULK1. We also discuss the way that GRASP55, the conserved player of
unconventional secretion, negatively regulates removal of damaged mitochondria by
mitophagy, which might be due to competition between secretory and degradative
autophagy. Taken together, these data indicate there is a conserved, unconventional
secretory pathway involving GRASP and autophagy. It also suggests that although
secretory and degradative autophagy share some core components, secretory autophagy
also involves specialized molecular machinery to execute its unconventional secretory
function and balance with degradative autophagy.
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CHAPTER 1

INTRODUCTION
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1.1 Unconventionally-secreted Proteins
Most eukaryotic proteins containing internal or N-terminal signal peptides are secreted by
the ER/Golgi-dependent conventional secretory pathway. However, some cytosolic or
nuclear proteins without such leader peptides can still be delivered into extracellular
space by relatively elusive pathway(s) 1. Pro-inflammatory cytokine interleukin-1β (IL1β) is one of the earliest examples to lack a hydrophobic signal common in most secreted
proteins 2 and to be secreted unconventionally 3. At the same time, some signal peptidecontaining proteins are also shown to be delivered unconventionally in a COPII/Golgiindependent manner. Integral protein Cystic Fibrosis Transmembrane conductance
Regulator (CFTR)

4

and the Drosophila melanogaster α integrin subunit

5

are the best

examples of such proteins. These two processes are both called unconventional protein
secretion.

A large number of proteins have been identified to be secreted/trafficked
unconventionally (Table 1). These proteins are shown to be involved in wound healing,
cancer

angiogenesis,

cancer

metastasis,

inflammation,

cytoprotection,

and

neurodegeneration. Also, these proteins are often released during stress conditions and
some of them have distinct but related intracellular and extracellular functions. Therefore,
it is speculated that unconventional secretion might have developed early in the evolution
before conventional secretion to rapidly connect diverse processes without going through
extraordinary regulations 6. Unconventional secretion might also be the mechanism to
rapidly react to stress conditions.
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Table 1
Examples of unconventionally secreted/trafficked proteins
Name

Function

References

Acb1/AcbA

Regulates spore viability

7, 8, 9, 10

α -integrin

Actin cytoskeleton organization and transduction of
intracellular signals regulating cellular functions

5

CFTR

Ion channel which transports chloride and thiocyanate

4, 11

ions across epithelial cell membranes
FGF2

Mediates wound healing and angiogenesis

12, 13, 14

Galectin1/3

Promotes cancer progression and metastasis

14, 15

HMGB1

Promotes cancer proliferation, angiogenesis, and

16, 17, 18, 19, 20

metastasis
IL-1α

Important for T cell priming, similar with IL-1β

14, 21, 22

IL-1β

Mediates inflammation, fever, cell proliferation,

14, 21, 22, 23, 24,

differentiation, and apoptosis

25, 26, 27, 28

Associated with Parkinson’s disease, Alzheimer’s

29

UCH-L1

disease
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1.2 Known Factors for Unconventional Protein Secretion
Although an increasing number of unconventionally-secreted proteins were revealed,
there

are only a few factors discovered that play a role in unconventional protein

secretion. Caspase-1 and GRASP are the most studied ones among those few factors.
1.2.1

Golgi Reassembly Stacking Proteins (GRASP)

Mammalian cells have two homologues of GRASP, GRASP65 and GRASP55, localizing
in cis- and medial-Golgi respectively (Figure 1.1A) 30. Both GRASPs have conserved Nterminal PDZ domains and less-conserved C-terminal Serin/Proline-Rich (SPR) domains.
Both GRASPs are heavily phosphorylated at Serine/Proline-Rich domain during mitosis
and are considered as tethering factors to mediate Golgi stacking and ribbon linking
(Figure 1.1B) 31. These functions are carried out by GRASPs via trans-oligomerization 32,
33

. GRASPs are first anchored to a membrane via myristoylation at Gly2 and via PDZ2

domain binding to GM130 or Golgin45, enabling GRASPs to lie parallel to the
membrane 34, 35, 36. Then, an internal ligand in the PDZ2 domain within a GRASP on one
membrane binds to the ligand binding pocket at the PDZ1 domain in another GRASP on
the opposing membrane, bringing adjacent membranes to form Golgi stacks or to link
Golgi ribbons 37.

Surprisingly, the single homologue of GRASP in D. discoideum, GrpA, was shown to
be involved in ER/Golgi-independent, unconventional secretion of cytosolic protein
AcbA, a factor required for differentiation of pre-spore cells 7. Also during epithelium
remodeling in D. melanogaster, dGRASP mediates unconventional transport of the
transmembrane protein α integrin to the plasma membrane 5.
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Figure 1.1 Cellular localization and domain structure of GRASP65 and
GRASP55
(A) Golgi localization of GRASP65 and GRASP5. (B) Functional domains of
GRASP.
A

B

Internal Ligand
Acylation
	
  

Ser-Pro-rich
Domain
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Figure 1.1 Cellular localization and domain structure of GRASP65 and GRASP55
GRASP65 and GRASP55 are localized on cis- and medial-Golgi respectively. Both
GRASPs have conserved N-terminal PDZ domains and less-conserved C-terminal
Serin/Proline-Rich (SPR) domains. Both GRASPs are heavily phosphorylated at the
Serine/Proline-Rich domain during mitosis and are considered as tethering factors to
mediate Golgi stacking and ribbon linking via trans-oligomerization. GRASPs are first
anchored to a membrane via myristoylation at Gly2 and via the PDZ2 domain binding to
GM130 or Golgin45, enabling GRASPs to lie parallel to the membrane. Then, an internal
ligand at the PDZ2 domain within a GRASP on one membrane binds to the ligand
binding pocket at the PDZ1 domain in another GRASP on the opposing membrane,
bringing adjacent membranes to form Golgi stacks or to link Golgi ribbons.
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However,

whether

GRASP

is

generally

involved

in

the

unconventional

secretion/trafficking of other leaderless proteins and the mechanism by which a Golgi
protein is involved in the ER/Golgi-independent unconventional secretion remains to be
elucidated.
1.2.2

Caspase-1

Caspase-1 is a protease, which cleaves the precursor forms of IL-1β, IL-18 and IL-33 into
active forms. Caspase-1 itself is usually activated by inflammasome components, which
respond to various internal and external stimuli including endogenous danger signals (e.g.
endogenous ATP released during cell death) 27, exogenous toxic compounds (e.g. Alum
and Silica) 38, and pathogen-associated molecular patterns (PAMPs, e.g. microbial toxin
Nigericin) 39, 40.

Interestingly, active Caspase-1 has been reported to regulate unconventional secretion
of pro-IL-1α, FGF-2, Caspase-1 itself, and many other leaderless proteins like Galectin-3
and Annexin A2. Pro-IL-1α and FGF-2 even showed direct physical interactions with
Caspase-1, although they are not catalytic substrates of Caspase-1

14

. These findings

suggest that Caspase-1 itself or some unknown substrates of Caspase-1 might be
generally involved in the unconventional secretion.

However, whether Caspase-1 is serving as a general carrier, directly binding to all the
proteins, that were discovered to be unconventionally secreted in Caspase-1-dependent
manner, remains unknown. The relationship between Caspase-1 and GRASP55 during
unconventional secretion also requires further investigation.
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1.3 Unconventional Secretory Pathways
Unconventionally secreted/trafficked proteins can be divided into two general categories:
1) COPII/Golgi-bypassing unconventional trafficking of signal peptide-containing
proteins, 2) ER/Golgi-independent, unconventional secretion of signal peptide-lacking
cytosolic/nuclear proteins.
1.3.1 Golgi-independent unconventional trafficking of signal peptide-containing
proteins
These proteins contain signal peptides and can be inserted into the ER lumen. However
they are delivered later to the plasma membrane in a COPII/Golgi-independent manner.
CFTR is the best-characterized example of unconventionally trafficked signal peptidecontaining proteins. It is a cAMP-dependent chloride channel located at the apical
membrane of various epithelia in lung, pancreas, kidney, and intestine. Normally, CFTR
is transported unconventionally by COPII vesicles bypassing Golgi in a Syntaxin
5/ARF1/RAB1A/RAB2-independent manner, which is required for early conventional
secretory pathway 4. ΔF508, a deletion mutation in CFTR gene accounts for ~70% of the
Cystic Fibrosis cases

41

. This deletion prevents proper folding of CFTR and its

unconventional trafficking to the plasma membrane.

1.3.2 Unconventional secretion of signal peptide-lacking cytosolic/nuclear proteins
Five different kinds of unconventional secretory pathways have been proposed for signal
peptide-lacking cytosolic/nuclear proteins and can be divided into two categories:
vesicular and non-vesicular.
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Non-vesicular pathways
Non-vesicular pathways involve two mechanisms: 1) Direct traverse across the plasma
membrane, and 2) ABC transporter-dependent translocation.
1) Direct translocation across the plasma membrane
This type of pathway is well characterized through studies of the secretion of fibroblast
growth factor 2 (FGF2), a pro-angiogenic factor
membrane

lipids

phosphoinositide

42

. FGF2 first interacts with the acidic

phosphatidylinositol

(4,5)-bisphosphate

(PtdIns(4,5)P2) at the inner leaflet of the plasma membrane 13. After being phosphorylated
by Tec kinase at tyrosine residue 82, FGF2 is oligomerized by PtdIns(4,5)P2 and inserted
into the plasma membrane 43. Interaction with heparin sulfates at the outer leaflet of the
plasma membrane then induces translocation of FGF2 across the plasma membrane 12, 44.
HIV-1 Tat and annexin A2 are also reported to be secreted in a similar way 45, 46.

2) ABC transporter-dependent pathway
This pathway is responsible for translocating lipidated peptides and proteins across the
plasma membrane. In yeast Saccharomyces cerevsiae, the secretion of signal peptidelacking pheromone alpha-factor is mediated by Ste6

47

, a member of the ATP-binding

cassette (ABC) transporter family which regulates the translocation of peptides across the
ER membrane and cholesterol across the plasma membrane. In Drosophila melanogaster,
a geranyl-modified attractant of germ cell was also shown to be secreted by the ABC
transporter Mdr49, a functional homologue of Ste6 48.

	
  

9

Vesicular pathways
These pathways involve vesicular intermediates and are best understood for IL-1β
secretion. IL-1β is a pro-inflammatory cytokine and it belongs to IL-1 family cytokines,
which also include IL-1α, IL-18 and IL-33 8. It is one of the earliest examples of signal
peptide-lacking proteins that are secreted by ER/Golgi-independent unconventional
secretory pathways 3. Upon induction by TLR ligands (e.g. LPS), it is synthesized as a
35kDa-precursor protein. Subsequently, it is processed into the 17kDa-active form by
Caspase-1 -containing in inflammasome complex, which is activated by DAMPs
(Damage-associated molecular patterns, e.g. ATP, Monosodium urate crystals) and
PAMPs (Pathogen-associated molecular patterns, e.g. bacterial toxin nigericin, double
stranded-RNA) in the cytosol, then ultimately secreted into extracellular space

49

. The

exact mechanism of IL-1β secretion has been elusive. The following three pathways have
been proposed to mediate unconventional secretion of IL-1β (Figure 1.2):

1) Endolysosome exocytosis-dependent
In LPS-activated human monocytes, a fraction of pro-IL-1β and pro-Caspase-1 were
found to be contained within vesicles that co-fractionate with late endosomes and early
lysosomes on Percoll density gradients

23, 24

. However, pro-IL-1β was only partially co-

localizing with Cathepsin D (late endosomal/lysosomal marker) and Lamp1 (lysosomal
marker), indicating that pro-IL-1β-containing vesicles belong to a specialized subset of
endolysosomes. Subsequent stimulation by extracellular ATP triggered the efflux of K+
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Figure 1.2 Proposed pathways for unconventional secretion of IL-1β

Caspase-1
pro-IL-1ß

Caspase-1
IL-1ß

Caspase-1

Caspase-1

IL-1ß

IL-1ß

Caspase-1
IL-1ß
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Figure 1.2 Proposed pathways for unconventional secretion of IL-1β
Three pathways have been proposed to mediate unconventional secretion of IL-1β.
1) Exosome release through multivesicular bodies; 2) Microvesicle shedding; 3)
Exocytosis of secretory endolysosome. It is considered that the IL-1β-converting
enzyme Caspase-1 is trans-located to the vesicles and secreted together with Caspase1. However, the identity of the secretory vesicles remains elusive and no single player
involved in this process has been identified.
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from the cell, followed by Ca2+ influx and activation of three phospholipases:
phosphatidylcholine-specific phospholipase C and calcium-independent and -dependent
phospholipase A2. These ultimately resulted in secretory endolysosome exocytosis and
the secretion of mature IL-1β. Nevertheless, how pro-IL-1β might have been translocated
into the secretory endolysosomes remains elusive.

2) Microvesicle-dependent
In THP-1 human monocytic cell lines, microvesicles of <0.5 µm diameter were shown to
be shed from their plasma membrane rapidly within 2–5 s after activation of P2X7
receptors (cation-permeable ligand gated ion channels that open in response to the
binding of extracellular ATP) by ATP which is dependent on extracellular Ca2+. Within 2
min, bioactive IL-1β was present in the isolated microvesicles. The shed microvesicles
then released the IL-1β contained inside, into the extracellular space
studies failed to reproduce the observation of microvesicle shedding

26

50

. However, later

, implicating the

secretion of mature IL-1β is dependent on Ca2+ release from intracellular stores, rather
than an influx of extracellular Ca2+ 51.

2) Exosome release-dependent
The formation of IL-1β containing-internal vesicles within multi-vesicular bodies
(MVBs) and its subsequent fusion with the plasma membrane was also suggested to
regulate IL-1β secretion. Because IL-1β secretion from ATP-stimulated BMMs was
accompanied by the release of the MHC class II molecules (exosome markers), it
therefore was proposed that exosomes derived from MVBs contained both IL-1β and
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Caspase-1. However, MHC class II molecules are also a lysosomal marker and the
authors failed to isolate exosomes containing mature IL-1 β, thus additional experiments
were needed to support this mechanism 28.

To summarize, no solid conclusion of a single pathway for unconventional secretion
of IL-1β was established and none of the factors directly involved in IL-1β secretion have
been reported. Also, the steps of IL-1β processing and incorporation into vesicular
intermediates is still unknown. Given that autophagy is a topological inverter to capture
cytosolic proteins and components; and also considering autophagy’s close connection
with multi-vesicular bodies and membrane trafficking, it suggests autophagy as a
potential mediator for IL-1β secretion. Additionally, TLR signaling, which is important
for IL-1β synthesis, processing, and secretion in human monocytes 52, induces autophagy
in myelomonocytic cells

53

. Actually, recent studies in yeast about unconventional

secretion of Acb1 began to reveal the new secretory role of autophagy in unconventional
secretion8, 10.

1.4 Autophagy-based Unconventional Protein Secretion
Macroautophagy (referred as autophagy hereafter) is typically considered as a
degradative pathway for 1) digestion of cytoplasmic compartments to supply amino acids
during starvation

54

; 2) destruction of long-lived protein aggregates

55

and damaged

mitochondria 56, 57; 3) elimination of intracellular microbes like M. tuberculosis 58, 59.
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Recent studies in yeast about unconventional secretion of Acb1 shed light on a 4th
important function for autophagy. In S. cerevisiae, starvation induced secretion of Acb1
and this process required Grh1 (yeast homologue of GRASP). Mutants defective for
several Atg genes (Atg5, 7, 8, and 12) also failed to secrete Acb1 suggesting components
in autophagy pathways are required for starvation-induced unconventional secretion
Acb1. Vam3 (a syntaxin needed for the fusion of autophagosome with vacuole) and Ypt7
(yeast homologue of Rab7 required for the fusion of autophagosome with vacuole) were
not involved in this process indicating that fusion of autophagosome-like vesicles
containing Acb1 with the vacuole (lysosome-like structure in yeast) is not necessary for
starvation-induced unconventional secretion of Acb1. Nevertheless, the involvement of
Ypt6 (a Rab GTPase functioning in recycling of endosomal components), Tlg2
(endosomal t-SNARE which regulates membrane traffic through the yeast endocytic
system), Vps4 (an ATPase responsible for ESCRT-III disassembly and required for MVB
protein sorting), and Vps23 (a component of the ESCRT-I complex involved in ubiquitindependent sorting of proteins into the MVB sorting pathway) suggests that endosomal or
MVB components play a role in the unconventional secretion of Acb1. The requirement
of Sso1, a plasma membrane t-SNARE, also suggests that the fusion of autophagosomelike vesicles containing Acb1 with plasma membrane might have occurred during the
Acb1 secretion process 8 (Figure 1.3).

Similarly in yeast Pichia pastoris, starvation and rapamycin treatments (which are
often used to induce autophagy) both promoted unconventional secretion of Acb1, which
required Grh1 and autophagy proteins Atg 1, 6, 8, 9, and 17. Interestingly, Atg11, which
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is necessary for selective, receptor-dependent autophagy-related pathways, was also
shown to be involved, indicating the requirement of some selectivity in this process.
Vam7 and Ypt7, components required for fusion with the vacuole, were again shown not
to be involved. Spo14 (encodes PLD which is important for exocytosis) and Sso1 were
required for Acb1 secretion suggesting the fusion with plasma membrane is necessary for
this process 10.

All these data suggest the existence of a conserved unconventional secretory pathway
involving autophagy components and Grh1. This autophagy-based unconventional
secretory pathway is plausible since autophagy is a bulk topological inverter for cytosolic
proteins and components and provides a means to capture Acb1 into the lumen of
autophagosome-like structures. Subsequently, these vesicles containing Acb1 might
somehow avoid fusion with the vacuole for degradation, but rather are targeted to the
plasma membrane for secretion.

Further proof is needed to show that this autophagy-based unconventional secretory
pathway is conserved in higher eukaryotes. It is also unclear that if autophagosomes or
MVBs transport unconventionally secreted cargoes directly to the cell surface and how
autophagy recognizes these cargoes and avoids fusing with the lysosomes. Importantly,
these studies have not isolated any autophagosome-like vesicles containing Acb1.
Therefore, it is alternatively possible that the disturbance in organelle maturation affects
unconventional secretion indirectly. In addition, the interplay between GRASP and
autophagy during unconventional secretion needs to be further investigated.
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Figure 1.3 Autophagy-based Unconventional Secretion of Acb1 in yeast
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Figure 1.3 Autophagy-based Unconventional Secretion of Acb1 in yeast
In yeast, Acb1 is unconventionally secreted upon starvation and rapamycin treatment
(conditions that usually induce autophagy). It is dependent on several Atg-related
proteins: Atg1 and Atg17 (needed for autophagy initiation and autophagosome
formation), Atg5/7/8/12/9 (required for autophagosome formation and elongation),
Atg11 (involved in selective autophagy). It also requires endosomal proteins and
multivesicular body components, Tlg2, Ypt6, Vps4, and Vps23, whereas Vamp3,
Vamp7, and Ypt7, which are involved in the fusion with the vacuole (lysosome), are
not needed. Sso1 (plasma membrane t-SNARE) and Spo14 (required for exocytosis)
are involved. Grh1 (yeast GRASP) is also required, although its function is not clear.
In summary, it suggests that cytosolic protein Acb1 might have been captured into the
autophagosome-like vesicles, fused with multivesicular bodies and targeted to the
plasma membrane for secretion by somehow avoiding fusion with the vacuole.
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1.5 Autophagy Pathways
To better explore the autophagy-based unconventional secretion, it is necessary to take a
closer look into the molecular pathways of autophagy. There is a set of autophagyspecific factors (Atgs) involved in the execution of autophagy. In mammals, autophagy
initiating-ULK1 (mAtg1, mammalian orthologue of yeast Atg1) complex responds to
upstream cellular stress signals like starvation, hypoxia, ER stress, and microbe invasion
60

. Then Class III PI(3)K Beclin1 (mAtg6)/Vps34 complex initiates PI3P production,

recruits PI3P effectors like DFCP1 and WIPIs (mAtg18s)

61, 62

and mediates the

formation of a pre-autophagosomal structure named isolation membrane 63. The Atg5/12
ubiquitin-like conjugation system conjugates PE to LC3 (mAtg8) to elongate the isolation
membrane into the autophagosome

64, 65

. The Atg8s are ubiquitin-like proteins that are

suggested to play dual roles in the autophagosome formation by selectively incorporating
autophagic cargoes through interacting with different autophagic adaptor proteins and
promoting autophagosome elongation and closure

66, 67, 68

. Autophagic receptor proteins

such as p62 recruit ubiquitinated cargoes into the elongating autophagosome 69. Atg4B is
also reported to mediate autophagosome closure

70

. Proteins like UVRAG and TBK1

mediate autophagosome maturation by promoting its fusion with endosome and
lysosome, forming autolysosomes

71, 72

. Finally, the substrates captured inside the

autolysosomes, together with p62 and LC3 are degraded 73. (Figure 1.4)

1.6 Non-degradative Roles of Autophagy-related Proteins
The non-degradative roles of autophagy-related proteins are becoming increasingly
appreciated. It has been shown that autophagy-related proteins additionally participate in
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Figure 1.4

Overview of degradative autophagy pathway.
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Figure 1.4

Overview of degradative autophagy pathway in mammals.

Upon upstream cellular stress signals like starvation, hypoxia, ER stress, and microbe
invasion, autophagy initiating-ULK1 (mAtg1, mammalian orthologue of yeast Atg1)
complex initiates autophagy. Then Class III PI(3)K Beclin1 (mAtg6)/Vps34 complex
initiates PI3P production, recruits PI3P effectors like DFCP1 and WIPIs (mAtg18s),
mediates formation of pre-autophagosomal structure named isolation membrane. Atg5/12
ubiquitin-like conjugation system conjugates PE to LC3/GABARAPs (mAtg8) to
elongate the isolation membrane into the autophagosome. Autophagic receptor proteins
like p62, NBR1, and NDP52, recruit specific ubiquitinated cargoes into the elongating
autophagosome. Atg4B is also reported to mediate autophagosome closure. Proteins like
UVRAG and TBK1 mediate autophagosome maturation by promoting its fusion with the
endosome and lysosome, forming autolysosomes. Finally, the substrates captured inside
the autolysosomes, together with p62 and LC3 are degraded.
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various aspects of cell physiology including cell survival, apoptosis, protein sorting and
secretion, cell signaling, DNA repair, gene regulation, and the immune response 74. These
findings add extra strength to the hypothesis that autophagy is involved in unconventional
secretion rather than merely in degradative processes. In order to investigate autophagy’s
potential role in unconventional secretion, it is necessary to know the non-degradative
functions of autophagy-related proteins.

1.6.1 Non-degradative roles of ubiquitin-like Atg proteins
Atg8 (LC3 in mammals) and Atg12 are ubiquitin-like Atg proteins shown to be involved
in autophagosome formation. In human, there are six Atg8 homologues: LC3A/B/C,
GABARAP, GABARAPL1, and GABARAPL2 (GATE-16). They interact with at least
67 other proteins through LC3-interacting regions (LIRs). Several more cryptic LIRs that
are activated by the phosphorylation of serine and threonine residues in the vicinity of the
LIR have been identified, enabling us to broaden the scope of LC3-interacting proteins.
Among the non-autophagy related proteins that interact with mammalian Atg8s, they are
mostly GTPases

75

, GTPase- activating proteins (GAPs)

76, 77

and guanine-nucleotide

exchange factors (GEFs) 78. Several GTPases have been discovered to regulate autophagy
79, 80

and LC3 has been shown to interact with a GAP protein TBC1D5 as a regulatory

signaling platform

77

. Also, LC3’s interaction with GEF impaired its ability to promote

downstream signaling
replication

81, 82

78

and non-lipidated LC3 was shown to regulate the viral

. Additionally, Atg12–Atg5 conjugate was reported to suppress RIG-I or

MDA5-mediated signals, thus negatively affecting the production of type I IFNs 83, 84.
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1.6.2 Non-degradative roles of other autophagy-related proteins
UNC-51, the C. elegans orthologue of human ULK1, was shown to regulate axon
guidance

85

. Atg16 has been linked to regulated hormone secretion

86

and secretion

granule exocytosis 87. In osteoclasts, Atg5, Atg7, Atg4B and LC3 participate in polarized
Cathepsin K secretion

88

. Autophagic adaptor protein p62 is an important signaling hub

for multiple signal transduction pathways, such as NF-κB signaling, apoptosis, and Nrf2
activation 89. In addition, TBK1 which was shown to mediate autophagosome maturation
has additional role to phosphorylate transcription factor IRF3 and upregulate NF-κB
signaling 90.

1.7 Complexity in the Regulation of Autophagy and Non-degradative Processes
Mediated by Autophagy-related Proteins
Notably in higher vertebrates, autophagy-related proteins have several homologues,
isoforms or structurally-related proteins. For example, although yeast, C. elegans and
Drosophila possess only one Atg1, in higher vertebrates there are at least five different
kinases highly related to Atg1 (ULK1-ULK4 and STK36). Remarkably, the C-terminal
domain in ULK1 and ULK2, which mediates the interaction with Atg13 and FIP200, is
not conserved in ULK3, ULK4 and STK36. Only ULK1 and ULK2 have been found in a
complex with Atg13, FIP200 and Atg101

91, 92, 93

. Therefore, different mammalian Atg1

may play different role in regulating degradative autophagy and non-degradative
processes mediated by autophagy-related proteins.
As mentioned before, mammalian Atg8 has six homologues: LC3A/B/C, GABARAP,
GABARAPL1, GABARAPL2. LC3s are shown to be involved in elongation of the
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phagophore membrane whereas the GABARAP/GATE-16 subfamily is essential for a
later stage in autophagosome maturation

68, 94

. Correspondingly, there are several

autophagic receptor proteins identified: p62, NDP52, NBR1, Optineurin, c-Cbl, Nix, and
Smurf169, 95, 96, 97, 98, 99, 100, 101. These proteins are structurally related since they all possess
LC3-interacting regions (LIRs)

102

. Each of them targets specific uniquitinated cargoes

for degradation. For example, selective binding of LC3C to autophagic receptor protein
NDP52 is important for innate immunity in protection against Salmonella 103.

Mice have four different isoforms (Atg4A-D), the protease that activates LC3
orthologues and also deconjugates LC3-II to free LC3-I. Atg4B has been associated with
the secretion of otoconins by vestibular sensory cells of the inner ear

104

.

Atg4

homologues also displayed selective preferences towards diverse Atg8 substrates 105. The
selective interactions between Atg4 isoforms and Atg8 homologues, displays the
complexity in autophagy regulation and also suggests the potential involvement of
autophagy-related proteins in non-degradative processes.

Mammalian Atg18 has four homologues (WIPI1-4) and WIPI2 has four isoforms
(WIPI2A-D). They all belong to WIPI (WD-repeat protein interacting with
phosphoinositides) family, which contain seven WD40 repeats that can fold into 7-bladed
beta propeller proteins. WIPI1 and WIPI2 have been shown to be associated with
autophagy 106. The functions of other WIPI proteins remain to be defined.
To summarize, the expansion of the ATG8 family, autophagic receptor proteins, and
other autophagy-related proteins in higher eukaryotes suggests that the specific
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interactions between them may be involved in the complex regulation of specific
autophagy processes and also the non-degradative processes (e.g. unconventional
secretion) mediated by autophagy-related proteins.

1.8 Dissertation Objectives and Hypothesis
Studies in yeast revealed that autophagy, traditionally considered a degradative pathway,
regulates the unconventional secretion of Acb1 upon nitrogen starvation or rapamycin
treatment (conditions that induce autophagy). This autophagy-based unconventional
secretory pathway, which we term as secretory autophagy, also involves a yeast
homologue of Golgi Reassembly Stacking Protein (GRASP) that was shown to mediate
the unconventional secretion of several other proteins. However, whether this secretory
autophagy pathway is a generic process, which can be applied to other unconventionally
secreted proteins in higher organisms, needs to be tested. The mechanism in which this
secretory autophagy pathway differentiates from traditional degradative autophagy
pathway requires further investigation. The exact role of a Golgi protein GRASP during
the ER/Golgi-independent unconventional protein secretion remains elusive. In order to
answer these questions, we utilized bone marrow-derived macrophages to study the
unconventional secretion of IL-1β. I set out to test the hypothesis that there exists a
specialized molecular and membrane machinery within the autophagy pathway which
involves GRASP to carry out unconventional protein secretion. The objectives of this
study were to determine: 1) whether this secretory autophagy pathway involving GRASP
is conserved in mammalian cells; 2) how secretory autophagy pathway differs from
degradative autophagy pathway; 3) whether GRASP is also involved in the degradative
autophagy. Delineating this secretory autophagy pathway has both fundamental
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biological and translational significance since the potential autophagy dependentunconventionally secreted proteins are important in wound healing, cancer,
neurodegeneration, and inflammation, etc.
The specific aims of this study were:
SPECIFIC AIM 1: To test whether this secretory autophagy pathway is conserved
in mammalian cells.
SUB AIM 1.1 Test if the autophagic machinery is involved in the unconventional
secretion of IL-1β.
SUB AIM 1.2 Determine if autophagic compartments intersect with IL-1β.
SUB AIM 1.3 Investigate whether the conserved player of unconventional secretionGRASP has a role in starvation-induced unconventional secretion of IL-1β.
SPECIFIC AIM 2: Examine the molecular divergence between secretory and
degradative autophagy.
SPECIFIC AIM 3: Delineate whether GRASP is also involved in degradative
autophagy.

1.9 Chapter Summary
We tested the hypothesis and accomplished the proposed objectives by addressing the
following three specific aims:
Specific Aim 1 (Described in Chapter 2): We discovered that, in mouse BMMs,
induction of autophagy by starvation augmented the secretion of IL-1β and IL-18 in
NALP3 inflammasome-dependent manner in response to various inflammasome stimuli.
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While, Atg5 deficient-BMMs showed decreased level of IL-1β and IL-18 secretion.
Bafilomycin A1 treatment reduced starvation-induced IL-1β secretion indicating
autophagic maturation is required for starvation-induced IL-1β secretion. Also Rab8a, a
regulator of polarized sorting to plasma membrane, co-localized with IL-1β and LC3 and
its knockdown down-regulated IL-1β secretion. Importantly, the conserved regulator of
unconventional secretion, GRASP55 was involved in the starvation-induced secretion of
IL-1β and it was also required for autophagosome formation. This autophagy-based
unconventional secretion was not restricted to inflammasome substrates but also applied
to non-inflammasome substrate HMGB1. Altogether, these data suggest there might be a
conserved molecular pathway in both lower organisms and mammals, which involve
autophagy factors together with at least one of the two mammalian GRASPs to carry out
the extracellular delivery role.

Specific Aim 2 (Discussed in Chapter 3): We found that autophagy-based
unconventional secretion of IL-1β preferentially utilizes specific mammalian Atg8
isoforms, LC3A and GABARAP for the unconventional secretion of IL-1β. While not
TBK1 and ULK1 that were shown to positively regulate degradative autophagy, were not
required for this process. We further identified that less IL-1β is secreted from BMMs
derived from transgenic mice lacking the autophagic adaptor Sequestosome 1/p62. Knock
down of another adaptor protein NBR1 showed no effect. I also observed that GRASP55,
the conserved regulator of unconventional secretion, selectively co-localized with
WIPI2B and WIPI2D, but not with WIPI1. These findings strengthen the evidence for the
existence of a specialized secretory autophagy pathway and provide first insights into the
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divergence between degradative and secretory autophagy pathways.

Specific Aim 3 (Covered in Chapter 4): We showed that although GRASP55
knockdown

increases

mitophagy-dependent

removal

of

damaged,

superfluous

mitochondria, whereas it does not affect the long-lived protein degradation and M.
tuberculosis killing. GRASP55 appears to be involved in at least one aspect of
degradative autophagy, mitophagy. GRASP55’s negative regulation on mitophagy might
be beneficial to the autophagy-based unconventional secretion of IL-1β.
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2.3 Abstract
Autophagy controls the quality and quantity of the eukaryotic cytoplasm while
performing two evolutionarily highly conserved functions: cell-autonomous provision of
energy and nutrients by cytosol autodigestion during starvation, and removal of defunct
organelles and large aggregates exceeding the capacity of other cellular degradative
systems. In contrast to these autodigestive processes, autophagy in yeast has additional,
biogenesis functions. However, no equivalent biosynthetic roles have been described for
autophagy in mammals. Here, we show that in mammalian cells, autophagy has a hitherto
unappreciated

positive

contribution

to

the

biogenesis

and

secretion

of

the

proinflammatory cytokine IL-1β via an export pathway that depends on Atg5,
inflammasome, at least one of the two mammalian Golgi reassembly stacking protein
(GRASP) paralogues, GRASP55 (GORASP2) and Rab8a. This process, which is a type
of unconventional secretion, expands the functional manifestations of autophagy beyond
autodigestive and quality control roles in mammals. It enables a subset of cytosolic
proteins devoid of signal peptide sequences, and thus unable to access the conventional
pathway through the ER, to enter an autophagy-based secretory pathway facilitating their
exit from the cytoplasm.
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2.4 Introduction
Autophagy is a fundamental biological process in eukaryotic cells where it plays a
number of roles associated with quality and quantity control of the cytoplasm 1, 2. For the
most part, autophagy enables cellular viability

3, 4

by removing damaged organelles e.g.

depolarized or leaky mitochondria 5, digesting potentially toxic protein aggregates 6,
killing intracellular microbes 7, and supplying energy and nutrients to the cell
whole body

9

8

and the

by bulk autodigestion of the cytosol at times of starvation. Based on the

known and on yet to be uncovered functions, autophagy has broad impact in fundamental
biology

10

and in human health

2

including aging

11

, cancer

12

, neurodegeneration

6, 13

,

myopathies 14, metabolic disorders 15, infections, immunity, and inflammatory diseases 16,
17

.

The sensu stricto autophagy, often referred to as macroautophagy, involves Atg
factors-driven generation of intracellular membranes that sequester cytoplasmic targets
earmarked for autophagic processing 1. The principal components of the autophagic
signaling and execution machinery are: (i) a protein kinase network including Tor,
AMPK and Ulk1/2
kinase hVPS34

19

8, 18

(ii) lipid kinases, principally the class III phosphatidylinositol 3-

and potentially class I p110β

20

, in cooperation with Beclin 1 and its

multiple modifiers 21, 22; (iii) a protein and protein-lipid conjugation Atg system resulting
in a lipo-protein conjugate, LC3-II, which marks the autophagic membranes 1; and (iv)
Atg8- and LC3-interacting autophagic adaptors that recognize ubiquitinated targets
destined for autophagic capture

23

and may be associated, as in the case of

p62/sequestosome 1, with autophagosomal nucleation sites
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24

. The protein lipidation

system resulting in LC3-II is driven by the Atg5-Atg12/Atg16 complex acting as an E3
ligase equivalent that facilitates localized conversion of LC3-I into LC3-II, with the latter
consisting of the LC3 moiety conjugated to phosphatidylethanolamine at its C-terminus 1.
The cargo enveloped by autophagosomes normally follows what is considered to be its
principal destiny, i.e. degradation of the captured material after conversion of autophagic
organelles into degradative autolysosomes 1.

Although the central dogma of autophagy is that it is a degradative, disposal pathway,
it also participates in several biogenesis processes documented in yeast, e.g. the Cvt
pathway

1

and the unconventional secretion of Acb1

25, 26

. The secretion of proteins

devoid of leader peptides differs from the secretion of proteins endowed with this signal
that brings them across the ER membrane into the canonical secretory pathway. The
secretion of such leaderless peptides may involve unrelated pathways

27

, but some

common principles are beginning to emerge that are conserved at least for a subset of
unconventional secretion substrates, in particular a dependence of their secretion on the
Golgi reassembly stacking protein GRASP
Acb1

25, 26

25, 26, 28

. The recent findings in yeast with

, suggest that GRASP- and autophagy-dependent pathways may converge, but

it is unknown whether these relationships extend to mammalian cells.

One of the promising systems to address the question of the potential role of
autophagy in the unconventional secretion in mammalian cells

29

, is the extracellular

delivery of the proinflammatory cytokine IL-1β 30, 31. IL-1 family members IL-1β and IL18 (IL-1F4) are processed in the cytosol from their precursors upon inflammasome
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activation and are secreted without transiting through the conventional secretory
pathway. However, recent reports have indicated that autophagy plays an inhibitory role
in inflammasome and IL-1β activation

32, 33, 34

thus potentially negating the idea that

autophagy may contribute to the unconventional secretion of IL-1β. The mechanisms of
autophagy-based suppression of inflammasome activation and IL-1β secretion may be
indirect and seem to rely on autophagy-dependent mitochondrial homeostasis that
normally suppresses release of reactive oxygen species (ROS) 32 and mitochondrial DNA
33

, both of which can stimulate inflammasome. Alternatively, autophagic degradation of

the inflammasome components has also been proposed

34

but this has not been

experimentally tested.

Here, we have addressed the question of whether autophagy plays a direct role in
inflammasome and IL-1β activation and secretion. We found that, whereas basal
autophagy inhibits IL-1β secretion in concordance with the recent reports

32, 33

, induced

autophagy augments IL-1β secretion. We show that inflammasome and the autophagy
apparatus synergize during IL-1β secretion in cells stimulated to undergo autophagy. We
also show that autophagy induction cooperates with GRASP and Rab8a (a GTPase
controlling post-Golgi polarized sorting and exocytosis) in driving IL-1β secretion. We
thus define one of the first biogenesis functions of autophagy in mammalian cells and
show that at least one type of unconventional secretion utilizes autophagic machinery in
higher vertebrate cells.
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2.5 Results
2.5.1

Induction of autophagy promotes inflammasome-dependent IL-1β secretion

Whereas it has been found that basal autophagy reduces extracellular release of the major
proinflammatory cytokine IL-1β

32, 33

, we detected the opposite when autophagy was

induced in primary murine bone marrow derived macrophages (BMM) (Fig. 2.1).
Stimulation of autophagy by starvation strongly enhanced IL-1β secretion in response to
conventional NLRP3 (NALP3) inflammasome agonist nigericin (Fig. 2.1A). This effect
was also seen (Fig. 2.1B) in Western blots of caspase 1 and mature IL-1β of culture
supernatants from cells grown in the absence of serum, as conventionally done when
assessing IL-1β secretion by immunoblotting

35

. A reduced secretion in BMMs from

Atg5Fl/Fl LyzM-Cre+ mice, compared to BMMs from their Cre- littermates,

was

accompanied and contrasted by the higher level of cell-associated pro-IL-1β in Cre- vs
Cre+ BMMs (Fig. 2.1B). The BMM derived from Atg5Fl/Fl LyzM-Cre+ mice for these and
other experiments had, as expected, no detectable Atg5 (since the Atg5 gene is excised in
Cre+ macrophages; 36) and LC3-II, a key marker of autophagy (Fig. A1A).

The effects of induced autophagy on secretion of inflammasome substrates described
above were not limited to IL-1β, since secretion of another inflammasome-dependent
cytokine from the IL-1 family, IL-18 (IL-1F4), was enhanced when autophagy was
induced (Fig. 2.1C). Pharmacological induction of autophagy by mTOR inhibition with
pp242 (Torkinib) increased secretion of IL-1β by BMM (Suppl. Fig. 2.1B).
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Figure 2.1

	
  

Induction of autophagy enhances IL-1β secretion.
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Figure 2.1

Induction of autophagy enhances IL-1β secretion.

(A) Atg5fl/fl Cre− and Atg5fl/fl Cre+ bone marrow-derived macrophages (BMMs),
pretreated overnight with 100 ng/ml LPS, were stimulated for 1 h with the inflammasome
agonist nigericin (20 µM) with (Starvation; EBSS) or without (Full; full medium)
autophagic induction. Cell culture supernatants were assayed for murine IL-1β by
ELISA. Data represent mean values±s.d. (n≥3); *P<0.05. (B) LPS-pretreated Atg5fl/fl
Cre− and Atg5fl/fl Cre+ BMMs were stimulated with 20 µM nigericin for 1 h in
OptiMEM and the release of active caspase-1 and IL-1β was determined by
immunoblotting. (C) As in (A), assayed for IL-18. Data represent mean values±s.d.
(n≥3); *P<0.05. (D) LPS-pretreated BMMs were exposed to alum (250 µg/ml) for 1 h
with or without autophagic induction by starvation. Secreted IL-1β was measured as in
(A). Data represent mean values±s.d. (n≥3); *P<0.05. (E) LPS-pretreated BMMs were
exposed to silica (250 µg/ml) for 1 h with or without autophagic induction by starvation.
Secreted IL-1β was measured as in (A). Data represent mean values±s.d. (n≥3); *P<0.05.
(F) BMMs were transfected with scramble (Scr) control siRNA or siRNAs against ASC
and NLRP3. After 48 h following transfection, cells were treated overnight with LPS and
subjected to nigericin (20 µM) and starvation for 1 h. Data represent mean values±s.d.
(n≥3); *P<0.05. (G) Immunoblot analysis of ASC and NLRP3 knockdowns. (H) BMMs
were transfected with scramble (Scr) control siRNA or siRNAs against ASC and NLRP3.
After 48 h following transfection, cells were treated overnight with LPS and subjected to
silica (250 µg/ml) and starvation for 1 h. Data represent mean values±s.d. (n≥3);
*P<0.05. (I) Colocalization of IL-1β with the basal autophagic machinery factor LC3.
Fluorescence: LC3 (green, Alexa488); IL-1β (red, Alexa568). BMMs were from GFP–
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LC3 knock-in mice, treated with LPS then prepared for immunofluorescence microscopy
using fluorescently labelled antibodies against GFP and IL-1β. (J, K) A line fluorescence
tracing from images in (I). (L) Pearson's colocalization coefficient for IL-1β and LC3.
Pearson's coefficient was derived from three independent experiments with five fields per
experiment, for a total of 15 fields contributing to the cumulative result.
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An enhancement of IL-1β secretion upon induction of autophagy was also detected
when particulate inflammasome agonists, alum
2.1E)

38

and amyloid-β fibrils

39

37

(Fig. 2.1D, Fig. A1C), silica (Fig.

(Fig. A1D), were used as inflammasome inducers. The

enhancement of IL-1β secretion associated with autophagy induction was inflammasome
dependent, as IL-1β activation was diminished by knockdowns of the inflammasome
components ASC and NLRP3, regardless of whether the inflammasome agonist used was
nigericin or silica (Fig. 2.1F-H). The knockdowns of ASC and NLRP3 did not change
IL-1β expression (Fig. A1E, F). The increased secretion of IL-1β was not due to the
increased cell death or non-specific membrane permeability as LDH release showed a
kinetic lag behind release of IL-1β whether the inflammasome agonist used was nigericin
or silica (Fig. A2A-D).

The stimulation of autophagy promoted IL-1β secretion in an Atg5-dependent
manner, based on comparisons between BMM from Atg5Fl/Fl-LyzM-Cre+ mice and BMM
from their Atg5-competent (Atg5Fl/Fl Cre-) littermates (Fig. 2.1A). However, the loss was
not complete in Cre+ BMMs (Fig. 2.1A). We interpret the incomplete reduction in IL-1β
secretion in the absence of Atg5 as a net result of two opposing effects – one described
here as a product of positive contribution of induced autophagy on extracellular delivery
of IL-1β and the other being the recently reported negative regulation of IL-1β secretion
by basal autophagy

32, 33, 34

. In keeping with this interpretation and in contrast to the

stimulatory effects of induced autophagy (Fig. 2.1A-E, Fig. A1B-D), basal autophagy
negatively affected IL-1β and IL-18 secretion (Fig. A2E, F) in agreement with the recent
reports in cells not induced for autophagy 32, 33, 34.
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2.5.2 IL-1β and autophagic protein LC3 colocalize in the cytoplasm
How might induced autophagy enhance IL-1β secretion? We considered a model in
which autophagy, as a process that can translocate cytosolic proteins and other targets (en
masse or specific components) from the cytosol to the inside of vesicular compartments,
brought IL-1β into the lumen of autophagic vacuoles followed by exocytosis. When we
examined IL-1β and the key marker of autophagosomes LC3 by immunofluorescence
confocal microscopy, LC3 and IL-1β colocalized and displayed major similarities in the
overall intracellular organellar distribution (Fig. 2.1I-L). The overlap between IL-1β and
LC3 remained detectable when cells were treated with nigericin (Fig. A3A-C). These
observations indicate that autophagic organelles and IL-β intersect.

2.5.3 Inhibition of autophagy flux reduces IL-1β secretion
A question arose whether the LC3+ organelles containing IL-1β are on pathway to
degradation or facilitated IL-1β secretion. We first tested the effects of bafilomycin A1,
a conventional inhibitor of autophagic maturation, which acts as an antagonist of
vacuolar H+ ATPase and prevents lumenal acidification and autophagosomal cargo
degradation. If induction of autophagy acted to degrade IL-1β, bafilomycin A1 was
expected to increase IL-1β levels. Instead, bafilomycin A1 decreased IL-1β secretion in
cells stimulated for autophagy by starvation, whereas no change was observed with
bafilomycin A1 in cells undergoing basal autophagy only (Fig. 2.2A). Thus, autophagy
flux during autophagy induction was not inhibitory to IL-1β but was instead promoting
IL-1β secretion. A similar trend was detected with another inflammasome substrate, IL-
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Figure 2.2

Autophagic pathway progression promotes secretion of inflammasome
substrates.
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Figure 2.2

Autophagic pathway progression promotes secretion of inflammasome
substrates.

(A, B) LPS-pretreated BMMs were treated with 20 µM nigericin (Nig) and 100 nM
bafilomycin A1 (Baf) with (Starvation) or without (Full) autophagic induction for 1 h and
secreted IL-1β (A) and IL-18 (B) were measured. Data represent mean values±s.d. (n≥3);
*P<0.05. (C) LPS-pretreated BMMs were treated with 250 µg/ml of silica and 100 nM
bafilomycin A1 (Baf) with (Starvation) or without (Full) autophagic induction for 1 h and
secreted IL-1β were measured. Data represent mean values±s.d. (n≥3); *P<0.05. (D)
Colocalization of cathepsin B with the basal autophagic machinery factor LC3 and IL-1β.
Fluorescence; LC3 (green, Alexa488), IL-1β (red, Alexa568), and cathepsin B (blue,
Alexa633). BMMs from GFP–LC3 knock-in mice were treated with LPS and then
analysed for immunofluorescence. (E) Colocalization line tracing analysis from images
in (D). (F) LPS-pretreated BMMs were treated with 20 µM nigericin and cathepsin B
inhibitor CA-074 Me (10 µM), with (Starvation) or without (Full) autophagic induction,
for 1 h and secreted IL-1β was measured. Data represent mean values±s.d. (n≥3);
*P<0.05. (G) LPS-pretreated Atg5fl/fl Cre− and Atg5fl/fl Cre+ BMMs were stimulated
with 20 µM nigericin for 1 h in OptiMEM and release of cathepsin B was determined by
immunoblotting.
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18 (Fig. 2.2B). Equivalent relationships have been observed for IL-1β secretion whether
nigericin (Fig. 2.2A) or silica (Fig. 2.2C) were used as inflammasome agonists. The
absence of IL-1β or IL-18 sparing effects of bafilomycin A1 is in keeping with the
interpretation that autophagy is not degrading inflammasome components but that an
unobstructed autophagy pathway is necessary for inflammasome-dependent IL-1 family
members secretion.

2.5.4 Lysosomal hydrolase cathepsin B is a positive factor in autophagy-driven IL1β secretion
Next we investigated the role of lysosomal hydrolases, focusing on cathepsin B. We
observed that IL-1β and LC3 colocalized with cathepsin B (Fig. 2.2D,E). However,
cathepsin B did not play an inhibitory role. Similarly to bafilomycin A1, cathepsin B
inhibitor CA-074 suppressed IL-1β production. Instead of protecting IL-1β from
potential degradation, CA-074 Me strongly inhibited IL-1β secretion in cells stimulated
for autophagy by starvation (Fig. 2.2F). No differences in expression of pro-IL-1β were
observed in cells treated with bafilomycin A1 or CA-074 (Fig. A3D). Of further interest
was that cathepsin B (mature form) was secreted along with the inflammasome substrates
in a manner dependent on an intact autophagic apparatus: loss of Atg5 in BMMs from
Cre+ mice (Atg5Fl/Fl LyzM-Cre) diminished the levels of the secreted mature Cathepsin B
relative to BMMs from Cre- littermates (Fig. 2.2G). The findings with cathepsin B
inhibitor CA-074 indicate a positive role for cathepsin B in IL-1β activation and
autophagy-driven pathway of extracellular delivery of IL-1β. They can also help explain
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in part the observations that a lysosomal hydrolase, cathepsin B, assists in inflammasome
activation and IL-1β secretion in response to particulate inflammasome agonists 38, 39.

2.5.5 Rab8a, a regulator of polarized sorting to plasma membrane colocalizes with
IL-1β and LC3 and controls IL-1β secretion
We next addressed the features of the compartment where LC3 and IL-1β colocalized.
We observed an overlap between the LC3+ IL-1β+ profiles and Rab8a (Fig. 2.3A-C).
Rab8a is a regulator of polarized membrane trafficking, constitutive biosynthetic
trafficking, and plasma membrane fusion of insulin-responsive
carriers

41, 42, 43, 44

40

and other vesicular

. Rab8a also colocalized with LC3 and IL-1β in cells exposed to

nigericin (Fig. A4A-C). Rab8a was required for enhanced IL-1β secretion caused by
starvation-induced autophagy and inflammasome activation with nigericin, since siRNA
knockdown of Rab8a diminished IL-1β secretion from BMMs under these conditions
(Fig. 2.3D,E). Rab8a knockdown did not change pro-IL-1β mRNA levels (Fig. A4D).
Overexpression of dominant negative Rab8a mutant (S22N) inhibited IL-1β secretion
from RAW264.7 cells, employed in that experiment based on their high efficiency of
transfection (Fig. 2.3F) (verified by flow cytometry of GFP-Rab8a for equal yields).
Additionally, LC3+ IL-1β+ profiles were positive for subunits of the exocyst complex
(Fig. A4E-J). Exocyst has been shown to cooperate with Rab8a in polarized plasma
membrane delivery of vesicular carriers 44, 45. The presence of exocyst components on IL1β+ autophagic organelles was also in keeping with a recent report implicating exocyst in
autophagy 46. In summary, these experiments indicate that systems involved in vectorial
vesicular transport to the plasma membrane participate in autophagy-based
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Figure 2.3
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Figure 2.3

Rab8a is required for autophagy-activated IL-1β secretion.

(A) Colocalization of Rab8a with the basal autophagic machinery factor LC3 and IL-1β.
Fluorescence; LC3 (green, Alexa488), IL-1β (red, Alexa568), Rab8a (blue, Alexa633).
BMMs from GFP–LC3 knock-in mice were pretreated with LPS and analysed by
immunofluorescence microscopy. Arrows indicate triple colocalization. (B) Line tracing
analysis of fluorescence signal intensity. (C) Pearson's colocalization coefficient for IL1β and Rab8a. Pearson's coefficients were derived from three completely independent
experiments with >5 fields per experiment, for a total of ≥15 fields contributing to the
cumulative result. (D) BMMs were transfected with siRNAs against Rab8a or scramble
(Scr) control. At 24 h after the first transfection, cells were transfected again with siRNA,
treated with LPS and the day after subjected to nigericin in full medium for 1 h, and IL1β secretion measured. (E) Immunoblot analysis of Rab8a knockdown in BMMs. (F)
RAW 264.7 macrophages were transfected with GFP-tagged Rab8a constructs (WT, wild
type; S22N, dominant-negative mutant), treated overnight with LPS and stimulated for 1
h with 20 µM nigericin along with induction of autophagy by starvation. IL-1β secretion
was measured by ELISA. Data represent mean values±s.d. (n≥3); *P<0.05.
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unconventional secretion and that Rab8a is required for efficient autophagy-dependent
secretion of IL-1β.

2.5.6 GRASP55 controls secretion of IL-1β
Two studies in yeast

25, 26

have reported that autophagic machinery is required for

unconventional secretion of the protein Acb1, and that this pathway depends on the yeast
equivalent of a Golgi-associated protein GRASP in mammals

28, 47

. Mammalian cells

encode two GRASP paralogs, GRASP55 (GORASP2) and GRASP65 (GORASP1)

48, 49

.

We first tested whether any of the mammalian GRASPs were required for IL-1β
secretion. We could not obtain a good knockdown of GRASP65 (GORASP1) and thus
could not evaluate its involvement. However, a knockdown of GRASP55 diminished IL1β secretion (Fig. 2.4A; Fig. A5A). A similar downregulation of IL-18 secretion was
observed with GRASP55 knockdown (Fig. A5B). We next tested whether GRASP55
showed any detectable response to inflammasome stimulation. GRASP55 in resting cells
is mostly localized aligned within the perinuclear Golgi (Fig. 2.4B; Fig. A6A). However,
a fraction of it dispersed upon treatment of cells with the inflammasome agonist nigericin
(Fig. A6B) and was found juxtaposed and partially overlapping with LC3 profiles (Fig.
2.4B,C). Thus, GRASP55 responds to inflammasome stimulation and is important for
secretion of the inflammasome substrates IL-1β and IL-18.

2.5.7 GRASP55 controls autophagy initiation
In addition to being required for IL-1β secretion, GRASP55 showed functional effects on
LC3 and autophagy, tested by employing two core assays 50: LC3-II lipidation and the
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Figure 2.4

GRASP55 is required for autophagy-activated IL-1β secretion.

(A) BMM cells were transfected with scramble (Scr) control siRNA or siRNA against
GRASP55. After 48 h of transfection, cells were treated with LPS and the day after
subjected to 20 µM nigericin in EBSS, and secreted IL-1β was measured by ELISA. Data
represent mean values±s.d. (n≥3); *P<0.05. Inset: Immunoblot analysis of GRASP55
knockdown. (B) Immunofluorescence confocal microscopy analysis of LC3 and
GRASP55 distribution. LC3 (green, Alexa488), GRASP55 (red, Alexa568). BMMs were
pretreated overnight with 100 ng/ml LPS and either not stimulated (Ctrl) or stimulated
(Nig) for 30 min with the inflammasome agonist nigericin (20 µM) in full medium. (C)
Line tracings, analysis of fluorescence signal intensity from images in (B). (D) Pearson's
coefficients for LC3 and GRASP55 were quantified using SlideBook morphometric
analysis software as a measure of adjacency between GRASP55 and LC3 profiles.
Pearson's coefficients were derived from three independent experiments with five fields
per experiment, for a total of 15 fields contributing to the cumulative result.
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RFP-GFP-LC3 tandem probe. When GRASP55 was knocked down, autophagy initiation
was negatively affected, as LC3-II levels were lower in both untreated and bafilomycin
A1-treated cells (Fig. 2.5A, B). A partial downregulation of GRASP65 (to the extent that
it could be achieved in BMMs) suggested a minor synergistic effect with GRASP55 on
LC3-II levels upon induction of autophagy (Fig. A5C). Knocking down GRASP55
reduced the total number of autophagic puncta, and selectively reduced the formation of
autophagosomes but not their maturation (Fig. 2.5C, D). This was apparent from the data
obtained with the RFP-GFP-LC3 probe following published methods

51

, which showed

reduced GFP+RFP+ LC3 profiles (early autophagosome) and equal number of GFP-RFP+
LC3 profiles (mature autophagic organelles) in cells knocked down for GRASP55 (Fig.
2.5D). Thus, mammalian GRASP55, a paralog of GRASP from lower organisms that has
thus far been the sole definitive molecular factor associated with unconventional
secretion

27

, displays important and previously unappreciated positive regulatory effects

on autophagy induction. These findings strengthen the connections between autophagy
and GRASPs in general, and specifically demonstrate the role of mammalian GRASP55
both in autophagy initiation and in the secretion of leaderless inflammasome substrates
such as IL-1β and IL-18.

2.5.8

Autophagy-based unconventional secretion is not limited to proteolytically

processed inflammasome substrates
We next wondered whether the unconventional process described above is limited to
inflammasome substrates epitomized by IL-1β that are concomitantly with their secretion
proteolytically processed from precursor pro-proteins into mature forms. We tested
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Figure 2.5

GRASP55 controls autophagy initiation.

(A, B) Effect of GRASP55 on autophagy induction by measuring LC3-II. BMM cells
were transfected with GRASP55 siRNAs or scramble (Scr) control. At 72 h post
transfection, cells were induced for autophagy, treated or not with Bafilomycin A1 (Baf)
to inhibit autophagic degradation and LC3-II/actin ratios determined by immunoblotting
(A) followed by densitometry (B). Data represent mean values±s.d. (n≥3); *P<0.05. (C,
D) RAW 264.7 was transfected with GRASP55 siRNAs or scramble (Scr) siRNA
control. Following 48 h of siRNA treatment, cells were transfected with RFP–GFP–LC3
plasmid (GFP is sensitive to acidification, whereas RFP is not), after 24 h induced for
autophagy in EBSS for 1 h and autophagic induction and flux quantified (graph in D) by
determining the number of early autophagic organelles (GFP+RFP+ puncta) and
autolysosomal organelles (GFP−RFP+ puncta) per cell as illustrated in fluorescent
images (yellow arrows, GFP+RFP+; red arrows, GFP−RFP+). Total, yellow+red puncta
per cell. Data represent mean values±s.d. (n≥3); *P<0.05.
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whether induction of autophagy affected other proteins not connected to proteolytic
processing in the inflammasome, such as HMGB1 (high mobility group box 1 protein).
HMGB1 is a major pro-inflammatory alarmin or DAMP (damage associated molecular
pattern) normally present in the nucleus

52

. This chromatin-associated nuclear protein

(with additional intracellular and extracellular signaling roles), upon exposure to inputs
including those that induce autophagy

53, 54

, undergoes a complex set of biochemical and

localization changes. In the process, it first translocates from the nucleus into the
cytoplasm and then is released from the cytoplasm to act in tissue remodeling signaling
(when acting alone) or as an inflammatory mediator (when combined with bacterial
agonists or other alarmins such as IL-1β). When tested, starvation and nigericin cotreatment caused HMGB1 extracellular release in an Atg5-dependent manner (Fig. 2.6A).
HMGB1 band was detected by immunoblots in BMM culture supernatants upon
stimulation of cells with nigericin, whereas HMGB1 was largely diminished when
BMMs from Atg5Fl/Fl Cre-LyzM mice were tested (Fig. 2.6B). Nigericin was used in
these experiments as an inflammasome agonist based on the reports that HMGB1, along
with additional unconventional substrates, depends on inflammasome for secretion
although the protein itself is not subjected to proteolytic processing by caspase 1
56

29, 30, 55,

. These experiments show that autophagy-based unconventional secretion affects

release of HMGB1 in a manner similar to IL-1β. Our findings broaden the spectrum of
autophagy-based unconventional secretion substrates, and establish this type of
unconventional secretion as a more general process in extracellular delivery of cytosolic
proteins.
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Figure 2.6
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Figure 2.6

HMGB1 is an autophagy-based alternative secretion substrate.

(A) Atg5fl/fl Cre− and Atg5fl/fl Cre+ BMMs, pretreated overnight with 100 ng/ml LPS,
were stimulated for 1 h with 20 µM nigericin (Nig; inflammasome agonist) while
incubated in EBSS for induction of autophagy by starvation. Cell culture supernatants
were assayed for murine HMGB1 by ELISA. Data (normalized to sample with maximum
HMGB1 secretion in each experimental repeat; Cre−and Nig) represent mean values±s.d.
(n≥3); *P<0.05. (B) LPS-pretreated Atg5fl/fl Cre− and Atg5fl/fl Cre+ BMMs were
stimulated with 20 µM nigericin for 1 h in OptiMEM and the release of HMGB1 was
determined by immunoblotting.

	
  

65

2.6 Discussion
The data presented in this work outline several elements of the autophagy-based
unconventional secretory pathway in mammalian cells. This type of unconventional
secretion is shown here to support the extracellular delivery of inflammasome substrates,
in particular IL-1β and IL-18 and may potentially have a broader number of clients. A
relevant aspect of the process described here is that induction of autophagy is required to
observe the manifestations of this type of unconventional secretion. Since basal
autophagy suppresses spurious induction of inflammasome 32, 33, autophagy provides both
avoidance of unscheduled inflammasome activation and a platform for extracellular
delivery of inflammasome substrates. Since a number of hormones, cytokines, pathogen
associated molecular patterns, and danger associated molecular patterns

16, 53

are known

to induce or inhibit autophagy, a link between autophagy and secretion of major
immunomodulatory cytokines such as IL-1β could significantly influence the extent and
duration of inflammation. Connections between metabolic syndrome, high fat diet and
inflammasome activity are now beginning to be appreciated

57, 58

, and we propose that

autophagy-based unconventional secretion may be a key coupler between the metabolism
and inflammation. Since a number of genetic links have been found between autophagy
and idiopathic inflammatory diseases or infectious diseases with significant inflammatory
components

17

it is possible that at least in part the genetic associations between

autophagy risk loci and disease states may stem from altered autophagy-based
unconventional secretion of inflammatory cytokines.
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The role of autophagy was represented here by the effects of induction of autophagy
and by employing conditional knockout mice with a loss of Atg5 in macrophages. We
interpret the incomplete inhibition of IL-1β secretion upon Cre-dependent Atg5fl/fl
excision as a result of the composite effects of Atg5-dependent basal autophagy
(inhibitory)

32

and induced autophagy (stimulatory) although we cannot exclude the

possibility of slight leakiness of the Atg5

fl/fl

LyzM-Cre system or the existence of

additional pathways. Importantly, blocking autophagic maturation has not salvaged IL-1β
but rather inhibited its secretion. This appears to be in contrast to what has been reported
for Acb1 in yeast

25

. Moreover, cathepsin B activity was needed, suggesting that

autophagic organelles here did not function as mere cargo carriers but provided a
platform for activation of inflammasome and IL-1β. In keeping with these observations,
cathepsin B has been implicated in inflammasome activation in response to particulate
inflammasome agonists

38, 39

, such as those (alum, amyloid-β) used here in addition to

nigericin, but how the substrate and cathepsin B meet has hitherto not been defined. Our
data indicate that induction of autophagy enhances assembly of inflammasome-activating
components and suggest that autophagic organelles may be a platform for concentration
of components engaged in proteolytic activation of inflammasome components and
inflammasome substrates.

In keeping with this model of a muster station for

inflammasome components, activation and subsequent extracellular delivery, is the
translocation of pro-IL-1β to membranous organelles upon stimulation with the
inflammasome agonist nigericin, as previously observed by R. Sitia and colleagues

59

who have established early on that this process does not follow the conventional
secretory pathway.
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The autophagy-based unconventional secretion pathway in mammalian cells includes
GRASP, one of the peripheral Golgi proteins involved in lateral organization of Golgi
ribbons. Although the role of GRASP in alternative secretory pathway has been studied,
its exact mechanism of action has not been elucidated

28, 47

. We observed here a

potentially telling connection betweeen GRASP and autophagy, by showing that GRASP
affects autophagy induction, which places GRASP upstream of autophagy execution,
including the conjugation systems involved in LC3 lipidation. The response of GRASP to
nigericin stimulation in terms of its redistribution and juxtaposition to autophagic
organelles, further links autophagy, inflammasome and GRASP, although alternative
explanations are possible. The finding that Rab8a plays a functional role in autophagybased unconventional secretion is of significance not just by assigning a trafficking
regulator to this pathway but also by providing additional links with exocyst components,
implicated to cooperate with Rab8a in other systems 44, 45 and to play a role in autophagy
46

.

In summary, in this study we have uncovered the role of autophagy in the secretion of
cytosolic pro-inflammatory factors that cannot enter the conventional biosynthetic
pathway due to the absence of leader peptides that would bring them into the ER and the
organelles of the canonical secretory pathway. Cytosolic IL-1β and IL-18 are both
processed from their precursor proteins into their active forms via the inflammasome
apparatus

30, 31

, however the process that delivers the proteolytically activated IL-1β and

IL-18 to the extracellular environment has hitherto remained unclear. To be eligible for
export outside of the cell without invoking a pore mechanism, cytosolic proteins first

	
  

68

need to be brought somehow into the lumen of vesicular carriers, as previously shown by
others 59. We have elsewhere noted 16, 60 that autophagy is a bulk topological inverter for
cytosolic proteins and other molecules, ferrying them from the cytosol into the organellar
lumen. We now show that induction of autophagy does that with IL-1β in the process of
its secretion. In doing so, autophagic machinery cooperates with the Golgi-associated
factor GRASP and post-Golgi membrane trafficking and exocytosis regulator Rab8a.
Autophagy captures cytosolic IL-1β and brings IL-1β into the organelles of a specialized
unconventional secretory pathway.

Broadening the scope of autophagy-based alternative secretion pathway is the
observation that it facilitates exit from cells of the alarmin HMGB1. HMGB1 is a DAMP
that is actively released from immune cells unlike its passive release from several cell
types secondary to cell death

52

. It has been recently shown that inflammasome, rather

unexpectedly given that HMGB1 is not a known substrate for caspase-1 processing, plays
a role in HMGB1 release 55. One explanation that can be offered based on our studies is
that a role of inflammasome may not be related solely to proteolytic substrate processing
but that it may be hardwired into the secretory pathway studied here. This is in keeping
with the requirement for NLRP3 and ASC and not the caspase 1 activity for HMGB1
release as a recently recognized noncanonical inflammasome client 56. We propose here
that autophagy-based unconventional secretion may be used for extracellular delivery of
a spectrum of cytosolic proteins or processed cytoplasmic substrates, not restricted to the
proteins explored here, and possibly including other biological mediators such as the
recently discovered cryptides
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. A recent study that appeared while this work was in

69

revision suggests that an unconventional secretion process, also dependent on GRASP
and autophagic machinery, may facilitate plasma membrane delivery of mutant CFTR,
potentially expanding the range of substrates to integral membrane proteins 62. Given the
capacity for either bulk transport or selectivity when coupled with autophagic adaptors,
we predict that autophagy-based unconventional secretion serves a potentially broad
spectrum of yet to be uncovered physiological functions.

2.7 Materials and Methods

2.7.1 Macrophages
Murine bone marrow-derived macrophages (BMM) cells were prepared from femurs of
C57/BL6 mice, Atg5fl/fl LyzM-Cre mice

36

GFP-LC3 transgene knock-in mice

63

and their Cre-negative Atg5fl/fl littermates, and
as previously described

61

. RAW 264.7

macrophages were maintained and manipulated as previously described 61.

2.7.2 Pharmacological agonists, inhibitors, inflammasome and autophagy
To induce pro-IL-1β expression, cells were pretreated overnight with 100 ng/ml LPS
(Sigma). Inflammasome was induced with 20 µM nigericin (Sigma) for 1 h or with 250
µg/ml Alum (Thermoscientific) for 1 h or with 250 µg/ml silica crystals (MIN-U-SIL-15,
US Silica) for 1h or with 5 µM Amyloid-β peptide (Aβ; American Peptide Company)
fibrils prepared as described

64

. Cells were treated with 100 nM bafilomycin A1 (LC

Laboratories) or 10 µM Cathepsin B inhibitor (CA-074 Me) (Enzo Life Science).
Autophagy was induced for 1 h by starvation in EBSS or with pp242 in full medium
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(Torkinib; Chemidea). Starvation and other treatments (except for macrophage priming
with LPS done in advance) were carried out concurrently (i.e. initiated at the same time).

2.7.3 Transfections and siRNA knockdowns
BMM and RAW 264.7 cells were transfected by nucleoporation using Nucleofector
Reagent Kit V or Kit Mouse Macrophage (Amaxa/Lonza biosystems). For murine
NLRP3, ASC, Rab8a or GRASP knockdowns, cells were transfected with siGENOME
SMARTpool reagents (Dharmacon).

Rab8a SMARTpool
(GAAUAAGUGUGAUGUGAAU;GAAGACCUGUGUCCUGUUC;
GACCUACGAUUACCUGUUC;GAGCAGCCAUGGAGUCAAG),

ASC SMARTpool
(AUACAUCCCUACUUGGUGA;GCUUAGAGACAUGGGCUUA;
GCAACUGCGAGAAGGCUAU; CUGCAAACGACUAAAGAAG),

NLRP3 SMARTpool
(GUUCUUCGCUGCUAUGUAC; GCACCCAGGCUGUAACAUU;
UGAAGGACCCACAGUGUAA; UCACAUUCCUCUAUGGUAU),

GORASP1 SMARTpool
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(CAUGAAGGUGCGCGAGGUA; CAGAGGACAUUGGUUCUAG;
ACUCGAGGCUGAACAAGGA; GCUACGACCUCACAACUUA),

GORASP2 SMARTpool
(GAAGACCUGUUCAGCCUUA; UACCAAGUCUGAUGCCUUU;
GUAAACCAGUCCCUUGCUU; GAUCAUCACACCAAACUCU).
Non-targeting siRNA pool (Scrambled) was used as a control. Plasmid encoding tandem
RFP-GFP-LC3 fusion for quantification of autophagic maturation was from T. Yoshimori
(Osaka, Japan). Plasmids encoding Rab8a wt (wild type) and Rab8a S22N were from
Johan Peranen (University of Helsinki, Finland).

2.7.4 Antibodies, immunoblotting, detection assays, microscopy
Cells extracts were analyzed by standard immunoblot techniques with antibodies to proIL-1β (Abcam), NLRP3 (AdipoGen), ASC (Enzo Life Sciences), LC3 (Sigma),
GORASP1 (Novus), GORASP2 (Abcam), Rab8a (Abcam) and Actin (Sigma); staining
was revealed with Super Signal West Dura chemiluminescent substrate (Pierce). For all
conditions, cell-free supernatants were assayed by immunoblotting after TCA
precipitation for mouse IL-1β p17 (R&D), caspase-1 p10 (Santa Cruz Biotechnology),
HMGB1 (Abcam) and Cathepsin B (R&D) or by ELISA for mouse IL-1β (R&D), IL-18
(MBL) and HMGB1 (IBL). Immunofluorescence confocal microscopy was carried out
using a Zeiss LSM 510 Meta microscope (laser wavelengths 488 nm, 543 nm and 633
nm). Antibodies against endogenous proteins IL-1β (AbCam), Sec6 (Shu C. Hsu, Rutgers
University, NJ, USA), Cathepsin B (R&D), Rab8a (Abcam), GORASP1 (Novus),
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GORASP2 (ProteinTech Group), GM130 (BD), LC3 (MBL) and GFP (Abcam; for
BMMs

from

GFP-LC3

knock-in

transgenic

mice)

were

used

for

indirect

immunofluorescence analysis. Pearson’s colocalization coefficients were derived using
SLIDEBOOK 5.0 (Intelligent Imaging Innovations) applying the SLIDEBOOK 5 default
algorithm command “AND”. All Pearson’s coefficients were derived from 3 completely
independent experiments with 5 fields or more per experiment, for a total of ≥15 fields
contributing to the cumulative result.

2.7.5 Statistics
All data were analysed using two-tailed unpaired Student’s t tests. All experiments were
performed at least three times, with data representing means ± s.d. (standard deviation).

Supplementary data
Supplementary data are available at The EMBO Journal Online.
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CHAPTER 3

AUTOPHAGY-BASED UNCONVENTIONAL SECRETION OF IL-1β
SPECIFICALLY UTILIZES PARTICULAR AUTOPHAGY-RELATED
PROTEINS
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3.1 Abstract
Proteins without signal peptides can still be released into extracellular space via
unconventional secretory pathway(s) that remain to be defined. A class of leaderless
proteins, including the pro-inflammatory cytokine interleukin-1β (IL-1β), is processed in
the cytosol by proteolytic machineries, such as the inflammasome prior to secretion.
Previously, we found that autophagy, traditionally considered a degradative pathway,
regulates the unconventional secretion of IL-1β. Here, we further test the hypothesis that
there is a specialized molecular machinery for secretory autophagy pathway to be
differentiated from degradative autophagy by testing the effects of knocking down known
autophagy factors on the secretion of IL-1β from bone marrow-derived macrophages
(BMMs). We found that autophagy-based unconventional secretion of IL-1β
preferentially utilizes specific mammalian Atg8 isoforms, LC3A and GABARAP, but not
TBK1 and ULK1. We further identified that less IL-1β is secreted from BMMs derived
from transgenic mice lacking the autophagic adaptor Sequestosome 1/p62, while
knocking down another adaptor protein NBR1 did not show any effect. We also observed
that GRASP55, the conserved regulator of unconventional secretion, selectively colocalized with WIPI2B and WIPI2D but not with WIPI1. These findings strengthen the
evidence for the existence of a specialized secretory autophagy pathway and provide first
insights into the divergence between degradative and secretory autophagy pathways.
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3.2 Introduction
Most eukaryotic proteins containing N-terminal or internal signal peptides are secreted
via the ER/Golgi-dependent conventional secretory pathway. However, leaderless
proteins, like interleukin-1β (IL-1β) and acyl-CoA binding protein (Acb1), can still be
released into the extracellular space via unconventional secretory pathway(s)

1, 2, 3, 4

. The

suggested routes for the unconventional secretion of IL-1β are: 1) microvesicle shedding
5, 6

, 2) secretory endolysosome-dependent pathway

7, 8

, and 3) exosome release 9. Yet,

these studies did not capture IL-1β inside the proposed secretory intermediates.
Surprisingly, GrpA, the single homologue of GRASP (Golgi Re-assembly and Stacking
Protein) in D. discoideum, was shown to be involved in the ER/Golgi-independent
unconventional secretion of AcbA (homologue of Acb1), a factor required for the
differentiation of pre-spore cells

10

. Also, during epithelium remodeling in D.

melanogaster, GRASP mediates the unconventional transport of α integrin to the plasma
membrane 11. However, the exact molecular machinery remains elusive.

Recent studies in yeast and mammals shed the light on the new unconventional
secretory aspect of autophagy, a pathway previously considered primarily as degradative.
In yeast, several Atg proteins, Grh1 (yeast homologue of GRASP), proteins needed for
fusion with plasma membrane and multi-vesicular body components were shown to
mediate unconventional secretion of Acb1, upon starvation and rapamycin treatment
(which are often used to induce autophagy) 12, 13. In mammalian cells, the unconventional
secretion of IL-11β, IL-18, and HMGB1 depend on a pathway involving Atg5,
inflammasome, at least one of the two mammalian Golgi reassembly stacking protein
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(GRASP) paralogues, GRASP55 (GORASP2) and Rab8a

14

. Also, the unconventional

trafficking of the integral protein CFTR to the plasma membrane requires GRASP55 and
Atg proteins needed for autophagosome formation

15

. Autophagy is a bulk topological

inverter for cytosolic proteins and components, thus cytosolic/integral proteins might be
captured into the lumen of autophagosome-like structures, then targeted to the plasma
membrane for secretion without fusion with the lysosome for degradation. A lot of
unconventionally secreted proteins are released upon stress conditions and are involved
in inflammation, development, tissue repair, and cytoprotection

4, 16, 17, 18, 19

. Also

considering autophagy as an important cellular stress-response mechanism, autophagybased unconventional secretion might serve as an essential molecular pathway to mediate
the protective and regenerative processes.

There is a set of autophagy-specific factors (Atgs) involved in the execution of
degradative autophagy. Autophagy initiating-ULK1 (mammalian homologue of Atg1)
complex responds to upstream cellular stress signals, like starvation, hypoxia, ER stress
and microbe invasion 20. Then Beclin1/Vps34 complex initiates PI3P production, recruits
PI3P effectors like DFCP1 and WIPIs (mAtg18s)

21, 22

, mediates formation of pre-

autophagosomal structure named isolation membrane

23

. Atg5/12 ubiquitin-like

conjugation system conjugates PE to LC3 (mAtg8) to elongate the isolation membrane
into the autophagosome

24, 25

. The Atg8s are ubiquitin-like proteins that are suggested to

play dual roles in autophagosome formation by selectively incorporating autophagic
cargoes, through interacting with different autophagic adaptor proteins and promoting
autophagosome elongation and closure
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. Autophagic adaptor proteins like p62,

recruit ubiquitinated cargoes into the elongating autophagosome 29. Proteins like UVRAG
and TBK1 mediate autophagosome maturation by promoting its fusion with the
endosome and lysosome, forming autolysosomes

30, 31

. Finally, the substrates captured

inside the autolysosome together with p62 and LC3 are degraded.

Although the new secretory function of autophagy (which we term as secretory
autophagy hereafter) is beginning to be appreciated, it is still unclear that if
autophagosomes are directly delivering secretory cargoes to the cell surface since
autophagy-related proteins also have non-autophagic roles in cell signaling, transcription,
protein secretion, cell survival/apoptosis, and cellular transportation

32

. For example,

autophagic adaptor protein p62 is an important signaling hub for multiple signal
transduction pathways, such as NF-κB signaling, apoptosis, and Nrf2 activation 33. Also,
TBK1 which was shown to mediate autophagosome maturation has additional role to
phosphorylate transcription factor IRF3 and upregulate NF-κB signaling

34

. In addition,

Atg proteins that are involved in secretory autophagy also regulate degradative autophagy.
How do these two pathways interact with each other and make a balance? Since there are
several homologues of Atg proteins and autophagic adaptors, we hypothesized that
different homologues may carry out different roles in degradative and secretory
autophagy to differentiate these two processes.

In order to answer these questions, we took the approach to knock down several
known autophagy factors to test its effect on IL-1β secretion. Data show that secretory
autophagy preferentially uses specific mammalian Atg8 homologues, LC3A and
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GABARAP, together with the autophagic receptor protein p62. Positive regulators of
degradative autophagy, ULK1 and TBK1, turned out to play inhibitory roles in IL-1β
secretion. GRASP55 was observed to selectively co-localizes with autophagosome
precursor WIPI2B and WIPI2D, but not with WIPI1. These findings suggest that
secretory autophagy involves a specific molecular machinery to carry out its extracellular
delivery role.

3.3 Results
3.3.1 Secretory autophagy preferentially utilizes LCA and GABARAP
There are only one Atg8 in yeast and several homologues in mammals: LC3A/B/C,
GABARAP, GABARAPL1, and GABARAPL2 (GATE-16)

27, 28

. However, the exact

roles of different mammalian Atg8 remain largely unknown. In order to investigate the
roles of different Atg8s in the autophagy-based unconventional secretion of IL-1β, we
knocked down LC3A/B (mice do not have LC3C), GABARAP/L1/L2 in mouse BMMs,
then stimulated for autophagy induction and IL-1β processing using starvation and
NLRP3 inflammasome inducer Nigericin. We found significant reduction of IL-1β
secretion in the supernatant of BMMs knocked down with LC3A and GABARAP while
knocking down the other closely related homologues did not have any effect (Figure
3.1). This is still significant, considering Atg5 knockdown yielded about the same
percentage (~30%) of decrease (Data shown in Chapter 2, Figure 2.1A). Surprisingly,
LC3B, the most abundant and essential mammalian Atg8, was not required for the IL-1β
secretion. This suggests that some mammalian Atg8s might be predominantly involved in
secretory autophagy while others are used for degradation.
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Figure 3.1 Autophagy induced-unconventional secretion of IL-1β favors specific
LC3s/GABARAPs.
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Figure 3.1 Autophagy induced-unconventional secretion of IL-1β favors specific
LC3s/GABARAPs.
Mouse BMM cells were transfected with scramble (Scr) control siRNA or siRNAs
against LC3A/LC3B/GABARAP/GABARAPL1/GABARAPL2. After 48 h of
transfection, cells were pre-treated with LPS (100ng/ml) in full media and the day
after subjected to 20 mM nigericin in EBSS for 1h, and secreted IL-1β was measured
by ELISA. Data (normalized to the level of sample from scamble knockdown)
represent mean values ±s.e.m (n=4); Statistical significance was calculated using
student’s t-test. *p<0.05.
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3.3.2 TBK1 knockdown increases IL-1β secretion
Previously, our group reported that Bafilomycin A1, which is an inhibitor of V-ATPase
blocking autophagosome maturation, decreases IL-1β secretion

14

. This suggests that

autophagy-based unconventional secretion requires proper acidification of secretory
vesicles and autophagosome maturation. TBK1 is an atypical IKK that promotes
autophagosome maturation and degradation by delivering lysosomal protease Cathepsin
D to the autophagosome compartments

30, 34

. To address whether TBK1 is also involved

in the secretory autophagy, TBK1 was knockdown in BMMs, then treated with starvation
and nigericin. Knockdown of TBK1 caused 2-3 fold increase in starvation-induced IL-1β
secretion (Figure 3.2A). Accordingly, there was less intracellular pro-IL-1β in the cell
lysates of TBK1 knocked down cells (Figure 3.2B), which indicates that more pro-IL-1β
have been processed and secreted. These data suggest that TBK1 inhibits the starvation
induced-unconventional secretion of IL-1β and knocking down the positive regulator of
degradative autophagy might up-regulate secretory autophagy.

3.3.3 p62 is involved in IL-1β secretion while NBR1 is not required
We next tested whether different autophagic receptor proteins are involved in the
autophagy-based unconventional secretion of IL-1β. There are several autophagic
receptor proteins identified: p62, NDP52, NBR1, Optineurin, c-Cbl, Nix, and Smurf1
35, 36, 37, 38, 39, 40, 41

29,

. Each of them specifically targets certain substrates for degradative

autophagy. Less IL-1β is secreted from BMMs derived from transgenic mice lacking the
autophagic receptor Sequestosome 1/p62 (Figure 3.3A), while knocking down another
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Figure 3.2 TBK1 inhibits autophagy-induced unconventional secretion of
IL-1β.
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Figure 3.2

TBK1 inhibits autophagy-induced unconventional secretion of IL1β.

(A) BMM cells were transfected with scramble (Scr) control siRNA or siRNA against
TBK1. After 48 h of transfection, cells were pre-treated with LPS (100ng/ml) in full
media and the day after subjected to 20 mM nigericin in EBSS for 1h, and secreted IL1beta was measured by ELISA. Data (normalized to the level of sample from scamble
knockdown) represent mean values ±s.e.m (n=3); Statistical significance was
calculated using student’s t-test. *p<0.05.
(B) Immunoblot analysis of TBK1 knockdown in BMMs.
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closely related receptor protein NBR1 did not have any effect (Figure 3.3B). This
indicates that some autophagic receptor proteins may be involved in the cargo selection
for secretory autophagy or the unconventional secretion of IL-1β is affected by the
signaling processes directed by such adaptors.

3.3.4 GRASP55 selectively intersect with WIPI2B and WIPI2D
GRASP (Golgi Re-assembly and Stacking Protein) is a conserved regulator of
unconventional secretion in different organisms

4, 10, 12, 13, 14, 15

. However, it is still not

clear that why a Golgi protein is required for the ER/Golgi-independent unconventional
secretory pathway and what is the interaction between GRASP and autophagy pathway.
Previously, the mammalian homologue GRASP55 was shown to be involved in the
autophagosome formation, which can be either secretory or degradative (Figure 2.5) 14.
Considering GRASP55 as a tethering factor for Golgi ribbon linking and stacking,
GRASP55 may be involved in tethering pre-autophagosomal structures to form secretory
or degradative autophagosomes. So we tested if GRASP55 is co-localizing with some
early autophagosomal markers-WIPIs (mAtg18s)

21, 22

in U2OS-GFP-WIPI stable cell

lines. In normal condition (Full), WIPI1/2B/2D all show diffuse distribution inside the
cytosol. When autophagy was induced by starvation, WIPI2B and 2D form preautophagosome-like structures and localize in close proximity with GRASP55 (Figure
3.4). In contrast, WIPI1 forms punctated structures but does not co-localize with
GRASP55. This indicates that there might be a functional separation in these WIPIs.
Some WIPIs might be localized on degradative autophagosomes, whereas the others are
tethered by GRASP55 to make secretory autophagosome.
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Figure 3.3 p62 is required for autophagy-mediated unconventional secretion.
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Figure 3.3

p62 is required for autophagy-mediated unconventional secretion.

(A) Wild type or p62 knock out BMM cells were pre-treated with LPS (100ng/ml) and
the day after subjected to 20 mM nigericin (Ethanol as control) in EBSS for 1h, and
secreted IL-1beta was measured by ELISA. Data represent mean values ±s.e.m (n=3);
Statistical significance was calculated using student’s t-test. *p<0.05.
(B) Wild type BMM cells were transfected with scramble (Scr) control siRNA or
siRNA against NBR1. After 48 h of transfection, cells were pre-treated with LPS
(100ng/ml) in full media and the day after subjected to 20 mM nigericin in EBSS for
1h. Secreted IL-1beta was measured by ELISA. Data represent mean values ±s.e.m
(n=3); Statistical significance was calculated using student’s t-test. n.s. stand for “not
significant”.
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Figure 3.4 GRASP55 and WIPIs are localized in close proximity upon starvation.
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Figure 3.4 GRASP55 and WIPIs are localized in close proximity upon
starvation.
Immunofluorescence confocal microscopy analysis of WIPIs and GRASP55
distribution. U2OS cells stably expressing GFP-WIPI1 or GFP-WIPI2B or GFPWIPI2D were cultured in DMEM (full) or EBSS (starvation) for 2h 30min, then
stained for endogenous GRASP55. WIPIs (green, GFP), GRASP55 (red, Alexa568).
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3.3.5 ULK1 knockdown up-regulates IL-1β secretion
Seeing the differentiation between secretory and degradative autophagy at almost every
stage, we questioned that whether the fate of the autophagosome precursors are decided
from the very beginning to be either degradative or secretory. In order to investigate this,
we knocked down the autophagy-initiating kinase ULK1 (mAtg1) in BMMs and
measured the IL-1β secretion in the supernatant by ELISA. Intriguingly, ULK1
knockdown increased IL-1β secretion rather than decreasing it (Figure 3.5), which is in
correspondence with TBK1 knockdown. This is again suggesting that there might be a
competition between degradative autophagy and secretory autophagy pathway. Thus,
suppressing one pathway might cause up-regulation of the other one.

3.4 Discussion
In this study, we have identified additional players involved in secretory autophagy to
support the existence of a specialized unconventional secretory pathway mediated by
autophagy, which differs itself from conventional degradative autophagy at every step,
including initiation, elongation, recognition, and degradation. Especially, there are
several homologues or closely related proteins in some of the Atg-related proteins and
they seem to be playing different roles in secretory and degradative autophagy.

LC3A and GABARAP knockdown significantly decreased IL-1β secretion, while the
essential autophagy factor LC3B was not required. This is indicating that LC3A and
GABARAP might be involved in making secretory autophagosomes while LC3B is
mainly functioning during degradation. Similarly, p62-knockout BMMs showed reduced
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Figure 3.5 ULK1 knockdown up-regulates autophagy-based unconventional
secretion of IL-1β.
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Figure 3.5 ULK1 knockdown up-regulates autophagy-based unconventional
secretion of IL-1β.
BMM cells were transfected with scramble (Scr) control siRNA or siRNA against
ULK1. After 48 h of transfection, cells were pre-treated with LPS (100ng/ml) in full
media and the day after subjected to 20 mM nigericin in EBSS for 1h, and secreted IL1beta was measured by ELISA. Data represent mean values ±s.e.m (n=3).
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level of IL-1β secretion, whereas NBR1 knockdown did not affect this process. Although
this might suggest that adaptor proteins are involved in the unconventional secretion of
IL-1β, it is equally possible that p62-mediated signal transduction affects IL-1β secretion.
Therefore, it is necessary to test whether the transcriptional level of IL-1β is altered upon
p62 deficiency. Incomplete inhibition of IL-1β secretion is also noticed upon
LC3A/GABARAP knockdown or p62 knockout, although the synergic effects of Atg8
proteins and the autophagic adaptor proteins or the existence of additional
unconventional secretory pathways may explain this. It will be useful to check if some of
the mammalian Atg8 or autophagic receptor proteins play redundant roles in secretory
autophagy.

GRASP55 selectively co-localizes with early autophagosomal marker WIPI2B and
WIPI2D but not with WIPI1 upon autophagy induction. Considering GRASP55’s role in
mediating autophagosome formation, this may suggest that although WIPI1 and WIPI2
are both mammalian Atg18 homologues, their functions might be different, with WIPI2
being exclusively involved in secretory autophagosome formation.

The data about TBK1 and ULK1 was somehow unexpected. Previously, we showed
that Bafilomycin A1 treatment decreased IL-1β secretion, suggesting that proper
autophagosome maturation is required for secretory autophagy. Therefore, knockdown of
TBK1, a protein mediating autophgosome maturation, was expected to show a similar
effect. However, the effect was completely opposite that TBK1 knockdown significantly
increased IL-1β secretion rather than decreasing it. Although TBK1 inhibition and
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Bafilomycin A1 treatment both dampen autophagosome maturation, their effects on
secretory autophagy are opposite, possibly because their mechanisms are different. TBK1
knockdown diminishes the delivery of lysosomal protease Cathepsin D to
autophagolysosomal structures, thus it might suppress degradative autophagy and
somehow up-regulate secretory autophagy. I originally thought about the alternative
scenario for TBK1’s role in IL-1β secretion as a phosphorylating kinase for transcription
factor IRF3. Then knocking down TBK1 should down-regulate NF-κB signaling and thus
decrease IL-1β transcription and secretion. However, TBK1 knockdown is still
accompanied with increased IL-1β secretion. Therefore, TBK1 is downregulating the
unconventional secretion of IL-1β possibly in order to balance the two autophagy
pathways, secretory and degradative autophagy.

ULK1 knockdown showed similar results. Since there are also several homologues
(ULK1/2/3/4 and STK36) in mammalian Atg1 family

43

, it is possible that ULK1 is

exclusively used for degradative autophagy and others are involved in secretory
autophagy. It will be useful to knock down all these homologues and see their effects on
secretory autophagy. Taken together, these data suggest that there might be a balance
between degradative autophagy and secretory autophagy, and knocking down a positive
regulator of degradative autophagy may enhance the secretory autophagy pathway.

All together, these results demonstrate that although secretory autophagy and
degradative autophagy share some components needed for autophagosome formation and
cargo recognition, specific factors are required to determine their selectivity and the
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balance between the two pathways. However, we have only focused on pro-inflammatory
cytokine IL-1β. Therefore, it is necessary to test if these findings also apply to the
unconventional secretion of other cargos.

3.5 Materials and Methods
3.5.1 Cells
Murine BMM cells were prepared from femurs of C57/BL6 mice and p62-deficient and
proficient mice 44.Human osteosarcoma (U2OS) cell line stably expressing GFP-WIPI-1,
GFP-WIPI2B or GFP-WIPI2D were cultured in DMEM (Invitrogen) supplemented with
10% FCS (Thermo Scientific), 100 U/mL penicillin/100 µg/mL streptomycin
(Invitrogen), 0.6 mg/mL G418 (Invitrogen) at 37°C, 5% CO2.

3.5.2 Pharmacological agonists, inhibitors, inflammasome, and autophagy
To induce pro-IL-1β expression, cells were pretreated overnight with 100ng/ml LPS
(Sigma), induced with 20mM Nigericin (Invivogen) for 1h. Autophagy was induced for 1
h by starvation in EBSS (Sigma).

3.5.3 Antibodies, immunoblotting, detection assays and microscopy
Cells extracts were analysed by standard immunoblot techniques with antibodies to TBK1
(Abcam), pro-IL-1β (Abcam), Actin (Sigma); staining was revealed with Super Signal West
Dura chemiluminescent substrate (Pierce). For all conditions, cell-free supernatants were assayed
by ELISA for mouse IL-1β (R&D). Immunofluorescence confocal microscopy was carried out
using a Zeiss LSM 510 Meta microscope (laser wavelengths 488, 543). Antibodies against
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endogenous proteins GRASP55 (ProteinTech Group), GFP (Abcam) were used for indirect
immunofluorescence analysis.

3.5.4 Transfections and siRNA knock-downs
BMM cells were transfected by nucleoporation using Nucleofector Reagent Kit Mouse
Macrophage (Amaxa/Lonza Biosystems). For murine LC3A, LC3B, GABARAP,
GABARAPL1, GABARAPL2, TBK1, NBR1, ULK1 knockdowns, BMM cells were
transfected with siGENOME SMARTpool reagents (Dharmacon).
Murine LC3A SMARTpool
(GUAAGGAGGUGCAGCAGAU; ACCCAUCGCUGACAUCUAU;
GCGAGUUGGUCAAGAUCAU; CGACCGGCCUUUCAAGCAG)
Murine LC3B SMARTpool
(CAGUGAUUAUAGAGCGAUA; CCGAAGUGUACGAGAGUGA;
GCGCCGGAGCUUUGAACAA; GCUUGCAGCUCAAUGCUAA)
Murine GABARAP SMARTpool
(GAAAGCGUCUAUGGUCUGU; GAAGCGAAUUCAUCUCCGU;
GGAGCAUCCGUUCGAGAAA; CCGCUCUGAGGGCGAGAAA)

Murine GABARAPL1 SMARTpool
(GGAAGUACCUUGUGCCCUC; GGCCAGUUCUACUUCUUAA;
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GACCUGAGGACGCCUUAUU; GAGGACGCCUUAUUCUUCU)
Murine GABARAPL2 SMARTpool
(GAACACUUUUGGCUUCUGA; UAGACAAGAGGAAGUACUU;
GCGUGGAAUCCGCGAAGAU; GAUUCUUGUAUGUGGCCUA)
Murine ULK1 SMARTpool
(CCACUCAGGUGCACAAUUA; UCACAAAGCCCUGCUAUUG;
GCAUGGACUUUGAUGAAUU; UUACGGACCUGCUGCUUAA)

Murine ULK2 SMARTpool
(GUACGAAGGUCUAAUACCA; CGAAGGAAGUCGAAUGUCA;
GCACGGUACCUACAUAGUA; GGAAUUAUCAGCGCAUAGA)

Murine TBK1 SMARTpool
(GAAGCCGUCUGGUGCAAUA; UGACGGCGCAUAAGAUUUA;
CUACGAAGGACGACGCUUA; GUAUGAAG- CGUUUAAAGAU)
Murine NBR1 SMARTpool
(GCGGAGACCUGUUGUGAUA; GAAAGGGAGCUGUACAUUC;
GUACAGCCACCGCUAUUGA; CGAGGGUACCAUGUUGUA)

Non-targeting siRNA pool (Scrambled) was used as a control.

	
  

103

3.5.5 Statistics
All experiments were performed at least three times, with data representing mean
values±s.e.m (standard error). Data were analyzed using two-tailed unpaired Student’s ttests. *p<0.05; n.s. stands for “not significant”.
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CHAPTER 4

THE ROLE OF GRASP55 IN DEGRADATIVE AUTOPHAGY
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4.1 Abstract
GRASP (Golgi Reassembly and Stacking Protein) is a conserved regulator of
unconventional secretion, which has been shown to be associated with autophagymediated unconventional secretion of cytosolic proteins (e.g. Acb1, IL-1β, IL-18, and
HMGB1) and unconventional trafficking of integral proteins (e.g. CFTR) to the plasma
membrane. One of the two mammalian GRASP homologues, GRASP55, is involved in
autophagosome formation as well, which can be either secretory or degradative.
However, whether GRASP55 is also mediating degradative autophagy remains unknown.
Here, we report GRASP55’s involvement in at least one aspect of degradative autophagy,
mitophagy. Unexpectedly, GRASP55 knockdown up-regulated autophagy-dependent
removal of dysfunctional, superfluous mitochondria instead of dampening it. This
suggests that GRASP55 might be a shared-component between secretory and degradative
autophagy balancing these two processes. Thus, knocking down GRASP55 may result in
abrogation in secretory autophagy while increasing the other autophagy pathwaydegradative autophagy.
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4.2 Introduction
GRASP55 is one of the two mammalian homologues of GRASP (Golgi Reassembly and
Stacking Protein). It has two conserved N-terminal PDZ domains and less-conserved Cterminal Serin/Proline-Rich (SPR) domain. It is heavily phosphorylated at Serine/ProlineRich domain during mitosis and are considered as tethering factors to mediate medialGolgi stacking and ribbon linking 1.

Surprisingly, the single homologue of GRASP in D. discoideum, GrpA, was shown to
be involved in ER/Golgi-independent unconventional secretion of cytosolic protein
AcbA, a factor required for differentiation of pre-spore cells 2. Also during epithelium
remodeling in D. melanogaster, dGRASP mediated unconventional transport of
transmembrane protein α integrin to the plasma membrane 3. Studies in yeast further
revealed that Grh1 (yeast homologue of GRASP), together with several Atg proteins,
proteins needed for fusion with plasma membrane, and endosomal/multivesicular body
components mediate unconventional secretion of Acb1 (yeast homologue of AcbA) upon
starvation and rapamycin treatment (which are often used to induce autophagy)

4, 5

. In

Chapter 2, we discussed about that starvation-induced autophagy together with
GRASP55 contribute to the unconventional secretion of IL-1β, IL-18, and HMGB1 in
mammalian cells 6. Another research group also reported that GRASP55 and autophagy
proteins regulate the unconventional trafficking of mutant ΔF508-CFTR to the plasma
membrane. Importantly, transgenic expression of GRASP55 in ΔF508-CFTR mice
restores CFTR function and rescues mouse survival without apparent toxicity 7. We
further discovered that autophagy-based unconventional secretion of IL-1β specifically
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utilizes particular autophagy-related proteins LC3A, GABARAP, and p62 but not TBK1
and ULK1. These all imply the existence of a conserved specialized pathway for
unconventional secretion/trafficking, which involve autophagy proteins and GRASP. It
also suggests the potential application of autophagy and GRASP on the treatment of the
diseases

(inflammation,

cystic

fibrosis,

etc.)

involving

unconventionally

secreted/trafficked proteins. However, the potential interplay between GRASP and
autophagy hasn’t been revealed fully.

We showed previously that GRASP55 controls autophagy initiation since its
knockdown decreased the level of LC3BII, the important marker of autophagosome. In
another assay, GRASP55 knockdown reduced the total number of autophagic puncta,
especially reducing the formation of autophagosomes but not their maturation.
Considering GRASP55 as a tethering factor for Golgi stacks, it is possible that GRASP55
tethers early autophagosomal structures to form autophagosomes needed for degradative
autophagy as well as autophagosome-like vesicles needed for unconventional secretion.
Thus, it was hypothesized that GRASP55 is involved in degradative autophagy as well.
Investigating the potential involvement of GRASP55 in degradative autophagy is
essential for us to determine whether it is an exclusive factor for secretory autophagy or it
is a shared-component between secretory and degradative autophagy balancing these two
processes. It is also important when applying GRASP55 to treat diseases involving
unconventionally secreted/trafficked proteins without perturbing degradative autophagy.
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In order to test the potential involvement of GRASP55 in degradative autophagy,
GRASP55 was knocked down in wild-type BMMs and check its effect on degradative
autophagy by the following standard autophagy assays since autophagy is responsible for
the removal of intracellular pathogen 8, long-lived protein aggregates
mitochondria

10

9

and damaged

. 1) Degradation of long-lived proteins by proteolysis; 2) removal of

damaged mitochondria by mitotracker staining; 3) elimination of intracellular microbes
by M. tuberculosis killing.

Interestingly, GRASP55 knockdown resulted in increased removal of dysfunctional
mitochondria under both basal and induced autophagy, suggesting GRASP55 is
negatively regulating selective degradation of damaged, surplus mitochondria by
mitophagy.

4.3 Results
4.3.1 GRASP55 knockdown up-regulates mitophagy
Appropriate control of mitochondrial turnover is essential for maintaining cellular
energetics and homeostasis under both basal and stressed conditions. Selective
degradation of damaged or superfluous mitochondria by autophagy (mitophagy) is
induced upon stress conditions like hypoxia, starvation, and tissue damage in order to
maintain cellular homeostasis and protect cells against accumulation of dysfunctional
mitochondria. Mitophagy has been associated with development, cancer, aging, and
neurodegeneration
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. Defects in mitophagy often result in enhanced Mitotracker
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Green staining suggesting accumulation of depolarized mitochondria and increased
mitochondrial mass (which can be labeled by Mitotracker Green FM dye).

In order to investigate the role of GRASP55 in mitochondria removal, GRASP55 was
knocked down in BMMs, stimulated cells with starvation and stained for Mitotracker
Green and Red to distinguish depolarized and polarized mitochondria. As reported
before, autophagy induction by starvation triggered removal of depolarized,
dysfunctional mitochondria (Mitotracker Greenhigh) and reduced mitochondrial mass as
shown by decrease in the percentage of Mitotracker Greenhigh cells. GRASP55
knockdown caused significant reduction in the percentage of Mitotracker Greenhigh cells
in full (basal) condition and even greater drop in starvation condition (autophagy
induction), indicating more dysfunctional mitochondria are removed and mitochondrial
mass is further decreased when GRASP55 is deficient upon autophagy induction (Figure
4.1 A-C). This suggests that GRASP55 knockdown is up-regulating mitophagy instead of
inhibiting it.

4.3.2 GRASP55 knockdown doesn not affect the degradation of long-live proteins
While the ubiquitin-proteasome system primarily degrades short-lived proteins,
autophagy regulates majority of degradation of long-lived proteins

14

. Autophagy

mediated-degradation of long-lived proteins is measured by proteolysis. Cells are usually
incubated overnight with C14 or H3-valine or leucine to label total cellular proteins, then
shortly incubated with excessive unlabeled valine or leucine in order to wash out the
labeling of short-lived proteins, which causes exclusive radioactive labeling of long-lived
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Figure 4.1 Dysfunctional mitochondria are cleared when GRASP55 is knocked
down.
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Figure 4.1

More dysfunctional mitochondria are cleared when GRASP55 is
knocked down.

BMM cells were transfected with scramble (Scr) control siRNA or siRNA against
GRASP55. After 72 h of transfection, cells were starved to induce autophagy for 1h
and stained with 300nM Mitotracker green FM (depolarized, unfunctional) and
Mitotracker red CMXRos (polarized, respiring). (A) Contour plots of FACS analysis
are depicted. (B) Quantification of percentage of Mitotracker Green FMhigh cells. Data
represent mean values ±s.e.m (n=3); Statistical significance was calculated using
student’s t-test. *p<0.05. (C) Immunoblot analysis of GRASP55 knockdown in
BMMs.
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proteins. Subsequently, cells are incubated again with cold valine or leucine that avoids
re-utilization of the radiolabeled amino acids for protein synthesis. Trichloroacetic acid
(TCA) precipitable radioactivity of the cell monolayers and the TCA soluble radioactivity
in the media are determined. Leucine or valine release (a measure of degradation of longlived proteins) is calculated as a ratio between TCA soluble supernatant and total cellassociated radioactivity.

So as to determine whether GRASP55 is involved in autophagy mediated-degradation
of long-lived proteins, GRASP55 was knocked down and measured its affect on
proteolysis in full media and Starvation media with or without autophagy flux inhibitor
Bafilomycin A1, which inhibits autophagic degradation. As reported before, starvation
treatment tends to increase proteolysis of long-lived proteins, while Bafilomycin A1
treatment inclines to decrease the clearance of long-lived proteins in both full and
starvation conditions. However, GRASP55 knockdown did not affect this process
(Figure 4.2).

4.3.3 GRASP55 knockdown doesn’t affect the in vitro M. tuberculosis killing
Besides mitochondrial removal and long-lived protein secretion, degradative autophagy is
also involved in M. tuberculosis killing. Autophagic killing of ubiquitinated mycobacteria
was first observed in vitro using BCG and M. tuberculosis-infected macrophages
18

15, 16, 17,

. It was also found that human IRGM (Immunity-related p47 guanosine triphosphatases)

participates in IFN-γ/Rapamycin/Starvation–induced autophagy in human macrophages

	
  

116

% Long-lived protein degradation

Figure 4.2 GRASP55 knockdown does not affect long-lived protein degradation.
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Figure 4.2 GRASP55 knockdown does not affect long-lived protein degradation.
BMM cells were transfected with scramble (Scr) control siRNA or siRNA against
GRASP55. After 48 h of transfection, cells were labeled with overnight with media
containing 1uCi/ml H3 Leucine, the day after cells were incubated in full or starvation
media with or without bafilomycin A1 for 90minutes. Trichloroacetic acid (TCA)
precipitable radioactivity of the cell monolayers and the TCA soluble radioactivity in
the media were determined. Leucine release (a measure of degradation of long-lived
proteins) was calculated as a ratio between TCA soluble supernatant and total cellassociated radioactivity. Data represent mean values ±s.e.m (n=3); Statistical
significance was calculated using student’s t-test.
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to resist against M. tuberculosis infection

19

. Autophagic receptor protein p62 delivers

ribosomal proteins (rpS30) and ubiquitinated complexes (Fau, a fusion of rpS30 with a
ubiquitin-like domain in its N-terminus) as inactive precursors to autophagosomes, which
are processed later as neo-antimicrobial peptides upon digestion in lysosomes 20. Innate
immunity regulator TBK-1 was shown to be required for IL-1β-induced autophagic
killing of mycobacteria in macrophages by promoting autophagosome maturation and
phosphorylating the autophagic adaptor p62 on Ser-403, a residue essential for its role in
autophagic clearance

21

. Recent studies also showed that extracellular bacterial DNA

escaped through bacterial secretion system ESX1 can be recognized by the STINGdependent cytosolic pathway, which later ubiquitinates the bacteria. Delivery of
ubiquitinated bacilli to autophagosomes was dependent on autophagic receptor p62,
NDP52 and also TBK1

22

. The ubiquitin ligase Parkin was shown to mediate K63-

ubiquitination of M. tuberculosis and recruitment of autophagic receptor proteins 23. The
mycobactericidal role of autophagy was also reported in vivo that autophagy not only
controls tuberculosis infection and but also prevents excessive inflammatory reactions in
the host 24.

To test the potential association of GRASP55 with autophagic killing of
mycobacteria, GRASP55 was knocked down in BMMs, infected them with M.
tuberculosis H37Rv strains and treated with starvation media to induce autophagic
killing. Subsequently, cells were lysed and survived mycobacteria inside were quantified
by colony forming unit (CFU) counting. As expected, autophagy induction by starvation
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Figure 4.3

GRASP55 knockdown does not affect the in vitro M. tuberculosis
killing.

SiScr
SiGRASP55

% M. tuberculosis Survival

*

	
  

140

n.s.

n.s.

Full

Starvation

120
100
80
60
40
20
0

120

Figure 4.3

GRASP55 knockdown does not affect the in vitro M. tuberculosis
killing.

After 72h of GRASP55 knockdown, BMMs was infected with M. tuberculosis H37Rv
(multiplicity of infection of 1/cell) for 1 hour, followed by washing, 4 hour in full and
starvation media, lysis with water to harvest bacteria, then plated. Autophagic killing
of M. tuberculosis was quantified by colony forming unit (CFU) counting. Data
represent mean values ±s.e.m (n=3); Statistical significance was calculated using
student’s t-test. n.s. stand for “not significant”. ); *p<0.05.
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significantly induced autophagic killing of M. tuberculosis as reflected by decreased
number of CFU counting (Figure 4.3). However, GRASP55 knockdown did not affect
M. tuberculosis killing either in Full (basal) or Starvation (autophagy induction)
conditions.

4.4 Discussion
With the observation that GRASP55 is regulating autophagosome formation, I originally
hypothesized that GRASP55 is also involved in degradative autophagy and knocking
down GRASP55 will dampen autophagic degradation of damaged mitochondria,
intracellular microbes, and long-lived protein. However, GRASP55 knockdown upregulated removal of damaged mitochondria instead of inhibiting it while it did not show
any effect on degradation of long-lived proteins and intracellular mycobacteria killing.
These results show that GRASP55 is negatively regulating at least one aspect of
degradative autophagy and it might a factor engaged in both secretory and degradative
autophagy balancing these two processes.

The unexpected negative regulation of GRASP55 in mitophagy might be associated
with the role of mitochondrial ROS in NRLP3 inflammasome activation. Inflammasome
inducers typically damage cells and release lysosomal (e.g. Cathepsin B) and
mitochondrial products (e.g. mitochondrial ROS) into the cytosol

25, 26

. Zhou et al.

discovered that NLPR3 inflammasome is activated by mitochondrial ROS production
triggered through NLRP3 inflammasome inducers and mitochondrial ROS production is
inhibited by mitophagy-mediated clearance of damaged mitochondria
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27

. Therefore,

during autophagy-mediated unconventional secretion, GRASP55 might inhibit mitophagy
to increase mitochondria ROS production and further trigger NLRP3 inflammasome
activation and autophagy-dependent IL-1β secretion. Vice versa, decreased IL-1β
secretion during GRASP55 knockdown might be related to decreased ROS production
resulted from enhanced removal of damaged mitochondria by mitophagy. However, it is
equally plausible that this effect is cell type-specific, since the experiment was
exclusively done in macrophages where mitophagy is associated with inflammasome
activation. It is necessary to test the involvement of GRASP55 in mitophagy in other cell
types and also test GRASP55 knockdown effect on NLRP3 inflammasome activity.

To summarize, we found previously an unexpected role of GRASP55 in mitophagydependent removal of damaged mitochondria. This suggests that GRASP55 is a shared
component fine-tuning secretory autophagy and degradative autophagy and GRASP55
might be engaged in autophagy-based unconventional secretion of IL-1β in multiple
ways.

4.5 Materials and Methods
4.5.1 Cells
Murine BMM cells were prepared from femurs of C57/BL6 mice.

4.5.2 Transfections and siRNA knock-downs
BMM cells were transfected by nucleoporation using Nucleofector Reagent Kit Mouse
Macrophage (Amaxa/Lonza Biosystems). For murine GRASP55 knockdown, BMM cells
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were transfected with siGENOME SMARTpool reagents (Dharmacon). Non-targeting
siRNA pool (Scrambled) was used as a control.

GRASP55 SMARTpool
(GAAGACCUGUUCAGCCUUA; UACCAAGUCUGAUGCCUUU;
GUAAACCAGUCCCUUGCUU; GAUC AUCACACCAAACUCU)

4.5.3 Antibodies and immunoblotting
Cells extracts were analysed by standard immunoblot techniques with antibodies to
GRASP55 (ProteinTech Group), LC3B (Sigma) and Actin (Sigma); staining was
revealed with Super Signal West Dura chemiluminescent substrate (Pierce).

4.5.4 Mitochondria removal assay
After 72h of GRASP55 knockdown, mouse bone marrow macrophage cells (BMMs)
were starved for 1h to induce autophagy. Then cells were trypsinized and stained with
300nM of Mitotracker green (depolarized, dysfunctional) and 300nM of Mitotracker Red
CMXRos (polarized, respiring) from Molecular Probes for 15 minutes at 37 degree. Flow
cytometry was carried out on the LSRFortessa (BD Biosciences) and data was analyzed
using FlowJo software (Tree Star).

4.5.5 Proteolysis
After 72h of GRASP55 knockdown, cells will be labeled with overnight with media
containing 1uCi/ml H3 Leucine, the day after cells will be incubated in full or starvation
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media with or without bafilomycin A1 for 90minutes. Trichloroacetic acid (TCA)
precipitable radioactivity of the cell monolayers and the TCA soluble radioactivity in the
media will be determined. Leucine release (a measure of proteolysis of stable proteins)
will be calculated as a ratio between TCA soluble supernatant and total cell-associated
radioactivity.

4.5.6 M.Tuberculosis killing
After 72h of GRASP55 knockdown, BMMs was infected with M. tuberculosis H37Rv
(multiplicity of infection of 1/cell) for 1 hour, followed by washing, 4 hour in full and
starvation media, lysis with water to harvest bacteria, then plated. Autophagic killing of
M. tuberculosis was quantified by colony forming unit (CFU) counting.

4.5.7 Statistics
All data were analysed using two-tailed unpaired Student’s t-tests. All experiments were
performed at least three times, with data representing mean values±s.e. (standard error).
n.s. stands for “not significant”; *p<0.05.
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CHAPTER 5

CONCLUSIONS AND FUTURE DIRECTIONS
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5.1 Introduction
The studies presented in this dissertation were designed and implemented to investigate
the role of autophagy in the unconventional secretion of pro-inflammatory cytokine IL-1β.
Although autophagy was primarily considered as a degradative pathway 1, recent studies
in yeast revealed the new role of autophagy in the unconventional secretion of Acb1 (a
factor needed for differentiation of pre-spore cells), which engage several autophagyrelated proteins, components of endosome/multi-vesicular bodies, and the conserved
regulator of unconventional secretion Grh1 (yeast homologue of GRASP), upon nitrogen
starvation or rapamycin treatment (conditions that induce autophagy) 2, 3. The notion that
autophagy might be involved in the unconventional secretion of signal-peptide-lacking
cytosolic/nuclear proteins is conceivable since autophagy is a topological inverter which
captures cytosolic proteins and components and it is also closely related to endosomes
and multivesicular bodies. Defining the autophagy-based unconventional secretory
pathway (which we term as secretory autophagy) has both fundamental biological and
translational significance since the potential autophagy dependent-unconventionally
secreted proteins usually have distinct but related intracellular and extracellular functions
and are important in wound healing, cancer, neurodegeneration, and inflammation 4, 5, 6.

However, since autophagy-related proteins are also involved in other non-autophagic
(non-degradative) processes, it is equally possible that its effect on unconventional
secretion in yeast is indirect 7. Also, whether this secretory autophagy is a conserved
process responsible for other unconventionally secreted proteins in higher organisms
needs to be tested. Additionally, the mechanism that differentiates this secretory
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autophagy pathway from traditional degradative autophagy pathway requires further
investigation. Besides, the exact role of a Golgi protein GRASP during the ER/Golgiindependent unconventional protein secretion and its possible involvement in degradative
autophagy remain unclear. In order to resolve these questions, bone marrow derivedmacrophages were utilized to study the involvement of autophagy in the unconventional
secretion of IL-1β, since autophagy has been implicated in the regulation of innate
immunity

8, 9, 10

and also TLR signaling that is important for IL-1β synthesis, processing,

and secretion in human monocytes

11

, induces autophagy in myelomonocytic cells

12

. It

was hypothesized that there is a specialized molecular and membrane machinery within
the autophagy pathway which involves mammalian GRASP to carry out unconventional
protein secretion of IL-1β. The objectives of this study were to determine: 1) whether
this secretory autophagy pathway involving GRASP is conserved in mammalian cells as
discussed in Chapter 2; 2) how secretory autophagy pathway differs from degradative
autophagy pathway as reviewed in Chapter 3; 3) whether GRASP is also involved in the
degradative autophagy as covered in Chapter 4.

5.2 Conclusions from Chapters
The main conclusions from chapters are presented in the following three sections. It also
highlights a number of interesting questions raised by the studies presented in this
dissertation that should be the focus of future work.
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5.2.1 Is secretory autophagy pathway involving GRASP conserved in mammals?
Starvation-induced unconventional secretion of IL-1β is dependent on Atg5,
inflammasome components, Cathepsin B, Rab8a, and at least one of the two mammalian
GRASP paralogues, GRASP55 (Chapter 2).

Data presented in Chapter 2 shows that autophagy induction by starvation augments
inflammasome-dependent unconventional secretion of IL-1β, IL-18, and HMGB1 while
Atg5 deficiency (a protein needed for autophagosome formation) and Bafilomycin A1
treatment (autophagosome maturation inhibitor) dampens this process. We also found
that IL-1β intersects with autophagosome marker LC3 and Rab8a (a GTPase involved in
polarized membrane trafficking). These all suggest that starvation-induced autophagy is
regulating unconventional secretion of IL-1β. This autophagy-based unconventional
secretion of IL-1β was also dependent on inflammasome, Cathepsin B (NLRP3
inflammasome activator), Rab8a, and GRASP55, one of the mammalian homologues of
GRASP. Interestingly, Caspase-1 and Cathepsin B secretion were also dependent on
Atg5. Additionally, GRASP55 was regulating autophagosome formation, which was not
seen in yeast studies. Thus, upon inflammasome and autophagy induction, IL-1β might
be unconventionally secreted after being captured together with Caspase-1 and Cathepsin
B into autophagosome-like vesicles (secretory autophagosomes) formed by GRASP55,
processed inside and trafficked to the plasma membrane in Rab8a-dependent manner.
This study reveals for the first time the new unconventional secretory role of autophagy
in mammalian cells and the possible mechanism of unconventional secretion of IL-1β,
which has been long unresolved. Later study also revealed GRASP55 and autophagy-
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dependent unconventional trafficking of CFTR to the plasma membrane 13. Together with
studies in yeast

2, 3

, it suggests the existence of an unconventional secretory pathway

involving GRASP and autophagy-related proteins (Figure 5.1).

However, autophagy seems to play dual role in IL-1β activation and secretion. Since
Atg16L1 deficiency up-regulates IL-1β production in mice

14

and autophagy inhibits IL-

1β processing/activation indirectly by affecting inflammasome activation, since
autophagy deficiency results in accumulation of damaged mitochondria that leads to
release of mitochondria ROS

15

and mtDNA

16

, which are both NLRP3 inflammasome

inducers. Additional studies also showed that pro-L-1β
inflammasomes can be targeted for autophagic degradation

18

17

and ubiquitinated

. These studies reflect the

housekeeping function of basal autophagy, which clears potentially harmful intracellular
components and limit un-necessary inflammation. The induced-autophagy-based
unconventional secretion of IL-1β early in the process to trigger necessary inflammatory
response against intracellular and extracellular danger signals might be followed by the
negative of regulation of inflammsome by autophagy. The latter becomes dominant at
later time points to suppress excessive inflammasome, which can be destructive to the
host. To summarize, autophagy negatively regulates inflammasome activation and
positively controls IL-1β secretion, with the net result being the product of these two
opposing processes depending on the time and extent of the triggers 19.

Although autophagy is shown to positively regulate unconventional secretion,
autophagosome-like vesicular intermediates containing the unconventionally secreted
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Figure 5.1 Autophagy-based Unconventional Secretion of IL-1β.
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Figure 5.1 Autophagy-based Unconventional Secretion of IL-1β.
Upon inflammasome activation and autophagy induction, pro-inflammatory cytokine IL1β, IL-18 and HMGB1 are unconventionally secreted in Atg5-dependent manner.
Bafilomycin A1 treatment blocked IL-1β secretion, indicating acidification and
maturation of autophagosome is required. IL-1β also intersects with LC3 and Rab8a,
suggesting IL-1β might be captured in autophagosome-like secretory vesicles and
delivered to the plasma membrane possibly mediated by Rab8a. Cathepsin B and
Caspase-1 are also secreted together with IL-1β in Atg5-dependent manner suggesting
the processing of pro-IL-1β might have occurred in the autophagosome-like secretory
vesicles. Autophagy-based IL-1β secretion also involved GRASP55 and GRASP55 was
found to mediate autophagosome formation suggesting GRASP55 might regulate
tethering of early autophagosome structures to form secretory autopahgosome.
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cargoes have not been isolated yet. Since autophagy-related proteins are also regulating
some non-autophagic (non-degradtive) processes 7, it is possible that autophagy’s effect
on unconventional secretion is indirect. Therefore, it is important to identify topological
features of the vesicles carrying unconventionally secreted cargoes either by visualization
or biochemical fractionation in the future. Furthermore, it is necessary to dissect the
autophagy-based unconventional secretory pathway to see how it distinguishes itself from
the conventional degradative autophagy pathway, which further supports the existence of
a specialized molecular pathway for secretory autophagy. Besides, since autophagy
regulated unconventional secretion of non-inflammasome substrate HMGB1, it will be
interesting to test if Caspase-1 is generally involved in autophagy-based unconventional
secretion and how it works in addition to acting as IL-1β converting enzyme. Importantly,
the role of GRASP55, the conserved player of unconventional secretion, has not been
identified yet. The interplay between GRASP55 and autophagy (secretory and/or
degradative) also remain elusive. In addition, more potential autophagy-dependent
unconventionally secreted cargoes should be discovered using mass spectrometry. Thus,
future studies should focus on these challenges.

5.2.2 How secretory autophagy differs from degradative autophagy?
Autophagy-based unconventional secretion of IL-1β specifically utilizes LC3A,
GABARAP, and p62 but not NBR1, TBK1, and ULK1. GRASP55 selectively co-localizes
with WIPI2B/2D but not with WIPI1 (Chapter 3).
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Chapter 3 focused on identification of more autophagy-related proteins involved in
starvation-induced unconventional secretion of IL-1β, which differentiates secretory
autophagy from degradative autophagy and adds supporting evidence to the existence of
a specialized molecular pathway for secretory autophagy. Data presented in Chapter 3
shows that LC3A and GABARAP are selectively consumed for autophagy-based
unconventional secretion of IL-1β. While LC3B, the most studied mammalian
homologue of Atg8 that mediates autophagosome elongation and closure, was not
required. It suggests that some mammalian Atg8s can be used for making degradative
autophagosomes whereas others are targeted for making secretory autophagosome-like
vesicles. It is useful to check if LC3A and GABARAP show increased co-localization/cofractionation with IL-1β upon inflammasome and autophagy induction compared to
LC3B either by immunofluorescence or subcellular fractionation. Also, it is necessary to
check if LC3A or GABARAP are secreted into the supernatant together with IL-1β.

The autophagic receptor protein p62, which targets ubiquitinated cargoes for
degradation, is involved in autophagy-based unconventional secretion of IL-1β while the
structurally related protein NBR1 was not. This suggests that p62 might recognize and
target IL-1β into the secretory autophagosomes as well while other autophagic receptor
proteins are exclusively targeting ubiquitinated cargoes for degradation. However, p62
knockout didn’t completely compromise the secretion of IL-1β, which suggests the
potential involvement of other autophagic receptor proteins (Optineurin, Nix, c-cbl, etc.)
or some unknown receptors for secretory cargoes. Vps23, ESCRT I complex subunit that
regulates ubiquitinated cargo sorting, can be a candidate for such receptors since it has
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been implicated in the unconventional secretion of Acb1 in yeast 2. It will be necessary to
knockdown all the receptors and define their roles in the autophagy-based unconventional
secretion of IL-1β. It will be also useful to check co-localization between the autophagic
receptor proteins and IL-1β upon stimulation. Considering that autophagic receptor
proteins usually target ubiquitinated substrates for degradation, it is possible that nondegradative ubiquitination of these secretory cargoes also serve as signals for them to be
recognized by autophagic receptor proteins, incorporated into secretory autophagosomes.
It is necessary to test whether these secretory cargos also undergo ubiquitination process
that is secretory but not degradative. Considering that some mammalian Atg8 show
preferential binding to the specific autophagic receptors to selectively target certain
cargoes (e.g. LC3C selectively bound by NDP52 is required for antibacterial autophagy
against Salmonella.), it is conceivable to hypothesize that specific combination of
mammalian Atg8 and autophagic receptor protein is responsible for autophagy-based
unconventional secretion of IL-1β. Thus, future studies should also identify the specific
Atg8-Receptor

combination

required

for

unconventional

secretion

by

immunoprecipitation.

Interestingly, autophagy-based unconventional secretion of IL-1β was promoted when
TBK1, a kinase required for autophagosome maturation, was knocked down. TBK1 has
been shown to interact with Rab8b, the closely related isoform of Rab8a that has been
implicated in autophagy-based unconventional secretion of IL-1β

20

. The negative

regulation of TBK1 on IL-1β secretion might be explained by investigating the
interaction between TBK1 and Rab8a. There might be competition between secretory and
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degradative autophagy and TBK1 may exclusively bind with Rab8b being more
important for degradative autophagy whereas it does not bind to Rab8a, thus suppress
secretory autophagy.

ULK1 knockdown showed similar results. Since there are several mammalian Atg1
homologues, it is reasonable to hypothesize that different mAtg1s play different role in
secretory and degradative pathways, with some involved more in degradative autophagy
whereas others affect secretory autophagy. Therefore, blocking one pathway may
promote the other pathway. It will be interesting to dissect the different roles of mAtg1s.
Additionally, it is equally plausible that ULK1 acts as an inhibiting kinase of GRASP55
since GRASP55 phosphorylation was shown to be important for unconventional
trafficking of CFTR 13.

In consistent with the findings listed above, GRASP55 showed selective co-localization
with specific WIPIs, WIPI2B and WIPI2D, but not with WIPI1. Since WIPIs are markers
of early autophagosomes, this result is consistent with my data that GRASP55 regulates
autophagosome formation as discussed in Chapter 2, which was not observed in yeast
studies. It also suggests that there might be functional separations among different WIPIs
in secretory and degradative autophagy. To investigate their role in secretory autophagy,
WIPI1/2B/2D should be knocked down and IL-1β secretion level should be measured.
Since GRASP55 is a tethering factor during Golgi stacking 21, it might be involved in the
tethering of WIPI puncta to make secretory autophagosomes. In order to test this,
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GRASP55 should be knocked down and the size and number of WIPI puncta must be
determined either by confocal microscopy or high-content microscopy.

5.2.3 Is GRASP55 involved in degradative autophagy as well?
GRASP55 negatively regulates removal of damaged mitochondria by mitophagy (Chapter
4).

Data presented in Chapter 4 shows that GRASP55 is involved in at least one aspect of
degradative autophagy, mitophagy. Interestingly, GRASP55 knockdown promoted
mitophagy-dependent removal of damaged, superfluous mitochondria, suggesting
GRASP55 is negatively affecting mitophagy. Despite GRASP55’s potential role during
secretory autophagosome formation, GRASP55 might have additional role to inhibit
mitophagy, which causes accumulation of damaged mitochondria and increase of
mitochondria ROS production and ultimately induces inflammasome activation. Thus,
GRASP55 might promote unconventional secretion of IL-1β in multiple ways. It is also
consistent with the arguments made in previous chapters that there might be a
competition/balance between secretory autophagy and degradative autophagy, and
inhibition of one pathway may result in up-regulation of the other.

However, further experiments should be performed to support this hypothesis.
Mitochondrial ROS production should be measured when GRASP55 is knocked down or
overexpressed and its effect on inflammsome activation should be examined upon
inflammasome induction. Since whether GRASP55 is directly involved in mitophagy is
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not clear, it is necessary to check GRASP55’s association with mitophagy regulators,
such as Parkin, PINK1, and Nix by westernblot and immunofluorescence. In addition,
GRASP55’s potential involvement in other cell-types should be tested since the study
was exclusively done in macrophages and it is possible that this effect is cell typespecific.

5.3 Implications for Current and Future studies
The studies presented in this dissertation defined on of the first biogenesis functions of
autophagy in mammals, which mediates unconventional secretion of IL-1β secretion.
This is consistent with studies in yeast, suggesting there is a conserved unconventional
secretory pathway that require autophagy-related proteins and GRASP which we can
term as secretory autophagy. The data presented here further supports the existence of a
specialized molecular pathway for secretory autophagy, which specifically utilizes some
of the autophagy-related proteins to carry out its unconventional secretory function. This
work also provides first insights to the divergence between secretory and degradative
autophagy (also reviewed in Ref. 22). Since there might be a competition/balance between
these two pathways, these aspects should be taken into consideration when applying
GRASP and autophagy into the treatment of diseases involving unconventionally
secreted/trafficked proteins.
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APPENDIX I
SUPPLEMENTARY MATERIALS FOR CHAPTER 2
Published as:
Dupont et al.,
http://www.nature.com/emboj/journal/v30/n23/suppinfo/emboj2011398as1.html
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Fig. A1 Autophagy-based unconventional secretion of IL-1β upon different
inflammasome incuders
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Fig. A1 Autophagy-based unconventional secretion of IL-1β upon different
inflammasome incuders
(A) Atg5fl/fl Cre- and Atg5fl/fl Cre+ BMM were induced for autophagy by starvation
in EBSS (Starv) or not (Full) for 1 h. Total cell extracts were analyzed by
immunobloting. (B) LPS-pretreated BMM were stimulated with 20 µM nigericin
(Nig) for 1 h with or without co-treatment with the mTor catalytic inhibitor pp242. IL1β secretion was measured by ELISA. (C) Bone marrow-derived macrophages
(BMM), pretreated with 100 ng/ml LPS overnight to induce pro-IL-1β expression,
were exposed to Alum (250 µg/ml) for 2 h with autophagic induction by starvation
(Starv) in EBSS or were incubated in full medium (Full), and secreted IL-1β assayed.
Data, means ± s.d. (n≥3); *, p<0.05. (D) LPS-pretreated BMM were stimulated with 1
or 5 µM amyloid-β peptide fibrils (Aβ) for 2 h with or without autophagic induction
by starvation and IL-1β secretion measured. (E) BMM were transfected with scramble
(Scr) control siRNA or siRNAs against ASC, NLRP3 or GRASP55. After 48 h
following transfection, cells were treated overnight with LPS and IL-1β mRNA levels
were quantified by real-time RT-PCR and internally normalized with respect to the
HPRT1 gene. Data, means ± s.d. (n=3). †, p≥0.05. (F) BMM were transfected with
scrambled control siRNA (Scr) or siRNAs against ASC, NLRP3 or GRASP55. After
48 h following transfection, cells were treated overnight with LPS and pro-IL1β level
assayed by immunoblots.

	
  

146

Fig. A2 LDH release upon inflammasome and autophagy induction and negative
regulation of basal autophagy on IL-1β secretion.
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Fig. A2 LDH release upon inflammasome and autophagy induction and negative
regulation of basal autophagy on IL-1β secretion.

(A-B) Bone marrow-derived macrophages (BMM), pretreated with 100 ng/ml LPS
overnight to induce pro-IL-1β expression, were exposed to nigericin (20 µM) for 20,
30 or 60 minutes with autophagic induction by starvation (Starv) in EBSS or were
incubated in full medium (Full). IL-1β secretion (A) and LDH released (B) was
measured by ELISA and by a cytotoxicity detection kit respectively. Data, means ±
s.e.m. (n≥3); *, p<0.05. (C-D) Bone marrow-derived macrophages (BMM), pretreated
with 100 ng/ml LPS overnight to induce pro-IL-1β expression, were exposed to silica
(250 µg/ml) for 20, 30 or 60 minutes with autophagic induction by starvation (Starv)
in EBSS or were incubated in full medium (Full). IL-1β secretion (C) and LDH
released (D) was measured by ELISA and by a cytotoxicity detection kit respectively.
Data, means ± s.e.m. (n≥3); *, p<0.05; †, p≥0.05. E. BMM from Atg5fl/fl Cre- and
Atg5fl/fl Cre+ mice were pretreated overnight with 100 ng/ml LPS, stimulated for 1 h
with the inflammasome agonist nigericin (20 µM) in full medium (Full). Cell culture
supernatants were assayed for murine IL-1β. Data, means ± s.d. (n≥3); *, p<0.05. F, as
in E, assayed for IL-18. Data, means ± s.d. (n≥3); *, p<0.05.
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Fig. A3 Co-localization between LC3 and IL-1β upon inflammasome activation.
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Fig. A3 Co-localization between LC3 and IL-1β upon inflammasome activation.

(A) Colocalization analysis of IL-1β with the basal autophagic machinery factor LC3.
Fluorescence: LC3 (green, Alexa 488); IL-1β (red, Alexa568). BMM from GFP-LC3
knock-in mice were pretreated with 100 ng/ml LPS overnight, stimulated for 30 min
with the inflammasome agonist nigericin (20 µM) in full medium. BMM were
prepared for immunofluorescence microscopy using fluorescently labeled antibodies
against GFP and IL-1β. (B) A line fluorescence tracing from images in A. (C)
Pearson’s colocalization coefficients for IL-1β and LC3. Data, means ± s.e.m. (n≥3).
(D) LPS-pretreated BMM were starved (starv) for 1h with 20 µM nigericin and
cathepsin B inhibitor CA-074 Me (10 µM) or with Bafilomycin A1 (Baf-100 nM). IL1β mRNA levels were quantified by real-time RT-PCR, normalized with respect to the
HPRT1 gene, and presented as fold increases. Data, means ± s.d. (n≥3); †, p≥0.05.
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Fig. A4 IL-1β intersect with LC3, Rab8a and Sec6, exocyst component.
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Fig. A4 IL-1β intersect with LC3, Rab8a and Sec6, exocyst component.
(A) Colocalization analysis of Rab8a with the basal autophagic machinery factor LC3
and IL-1β. Fluorescence; LC3 (green, Alexa488), IL-1β (red, Alexa568), Rab8a (blue,
Alexa633). BMM from GFP-LC3 knocking mice were pre-treated with LPS and
stimulated for 30 min with 20 µM nigericin in full medium. BMM were prepared for
immunofluorescence microscopy. White arrows, triple colocalization. (B) A line
fluorescence tracing from images in A. (C) Pearson’s colocalization coefficients for
IL-1β and Rab8a. (D) BMM were transfected twice with scramble (Scr) control
siRNA or siRNAs against Rab8a. After 48 h following transfection, cells were treated
overnight with LPS and IL-1β mRNA levels were quantified by real-time RT-PCR,
normalized with respect to the HPRT1 gene, and presented as fold increases. Data are
means +/- SDV. (E) Colocalization of Sec6 with LC3 and IL-1β. BMM from GFPLC3 knock-in mice were pre-treated with LPS and analyzed by immunofluorescence
microscopy. White arrows, triple colocalization (Sec6-IL-1β-LC3; turquoise arrows,
LC3-Sec6 colocalization. (F) Line tracing, fluorescence signal coincidence analysis.
(G) Pearson’s colocalization coefficients for IL-1β and sec6. (H) Colocalization
analysis of Sec6 with LC3 and IL-1β (as in A). White arrows, triple colocalization. (I)
A line fluorescence tracing from images in H. J. Pearson’s colocalization coefficients
for IL-1β and sec6. Pearson’s coefficients bars and error bars, means ± s.d. (n=3).
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Fig. A5 GRASP55 is regulating unconventional secretion of IL-1β and IL-18
under basal autophagy condition.
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Fig. A5 GRASP55 is regulating unconventional secretion of IL-1β and IL-18
under basal autophagy condition.

(A, B) BMM cells were transfected with siRNAs or scrambled (Scr) control siRNA.
After 48 h of transfection, cells were treated with LPS and the day after subjected to
20 µM nigericin in full medium, and secreted IL-1β (A) and IL-18 (B) were measured.
Data, means ± s.d. (n≥3); *, p<0.05. The number of cells in the experiment in panel A
(2x105 cells) was 2.8 times higher than in Fig. 4A (0.7x105 cells). (C) Effect of
GRASP65 on autophagy induction by measuring LC3-II. BMM cells were transfected
with GRASP65 or with GRASP65 and GRASP55 siRNAs or scramble (Scr) control.
At 72 h post-transfection, cells were induced for autophagy, treated or not with
Bafilomycin A1 (Baf) to inhibit autophagic degradation. All lanes are from the same
gel (one intervening lane was removed to avoid redundancy).
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Fig. A6 Co-localization between GM130 and GRASP55.
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Fig. A6 Co-localization between GM130 and GRASP55.
Fluorescent confocal microscopy images: GM130 (green, Alexa488), GRASP55 (red,
Alexa568). (A) Control, resting BMM. (B) Nigericin, BMM treated with 20 µM
nigericin.
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Supplementary Methods

Quantitative real time RT-PCR
Total RNA was extracted from BMM and cDNA was synthetized using a Cells-to-Ct Kit
(Applied Biosystems), according to the manufacturer’s instructions. Real-time PCR was
performed using SYBR Green Master Mix (Applied Biosystems), and products were
detected on a Prism 5300 detection system (SDS, ABI/Perkin-Elmer). The relative extent
of IL-1β expression was calculated using the 2eΔΔC(t) method. The results presented
herein are from three independent experiments, each of which was performed in
duplicate. Conditions for real time PCR were: initial denaturation for 10 min at 95°C,
followed by 40 amplification cycles with 15s at 95°C and 1 min at 60°C. The sequences
of the primers (IDT DNA Technologies, MA) were as follows: HPRT1 forward 5- GGA
GCG GTA GCA CCT CCT -3; HPRT1 reverse 5- CTG GTT CAT CAT CGCTAATCA
C -3; IL-1β reverse 5- TCT TCT TTG GGT ATT GCTTGG -3; IL-1β forward 5- TGT
AAT GAA AGA CGG CAC ACC -3

Extracellular LDH release assay
Lactate dehydrogenase (LDH) release was measured using a cytotoxicity detection kit
(Promega, Madison, WI). All LDH data are means ± standard error of the mean (s.e.m).

Supplementary discussion
Some of the nuclear staining with IL-1β in BMMs (e.g. in Suppl. Figs. S3 and S4) may
be nonspecific, but we cannot rule out functional roles (a topic beyond the scope of our
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study). IL-1 family members such as IL-1α and IL-1β are known to be distributed
between the cytoplasm and the nucleus, reflecting their dual functionality or to counter
excessive inflammation1. Of further note is that IL-1β has been observed in the nucleus
of microglia, a major macrophage cell type of the central nervous system 2.

Supplementary references
1.

Luheshi, N.M., Rothwell, N.J. & Brough, D. Dual functionality of interleukin-1
family cytokines: implications for anti-interleukin-1 therapy. British Journal of
Pharmacology 157, 1318-1329 (2009).

2.

Luheshi, N.M., Rothwell, N.J. & Brough, D. The dynamics and mechanisms of
interleukin-1alpha and beta nuclear import. Traffic 10, 16-25 (2009).
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APPENDIX II

MASS SPECTROMETRY RESULTS FOR AUTOPHAGY-BASED
UNCONVENTIONALLY SECRETED PROTEINS
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Methods
Mass Spectrometry
Murine bone marrow macrophage (BMM) cells were prepared from femurs of C57/BL6
mice, Atg5fl/fl LyzM-Cre mice (Atg5 knock-out) and their Cre-negative Atg5fl/fl
littermates (wild type). BMM cells were grown in 10cm dishes to 70% confluency. Cells
(each one dish) were pretreated overnight with 100ng/ml LPS (Sigma). On the following
day, cells were treated with 20µM inflammasome inducer nigericin (Invivogen) in EBSS
(autophagy inducer, Sigma) for 1 h.

Supernatant was collected and centrifuged at 2,500rpm for 5 minutes at 4°C. After
centrifugation, the supernatant was cleared by filtration (0.45 µm pore size). Then
supernatant was concentrated to 1ml with Amicon ultrafiltration units (3kDa MWCO,
Millipore). Protein concentrations were determined by BCA. 100µg protein of each
sample was precipitated with acetone.

Samples were digested by trypsin and labeled with Tandem Mass Tag (TMT)
reagents (Thermo Scientific). Peptides were then identified and quantified by tandem
mass spectrometry. Total of 307 proteins were identified using Mascot Search. 153
proteins are likely to be secreted in Atg5 dependent manner since its secretion is
decreased in the supernatant from Atg5 knockout BMMs. Among these, there were
several unconventionally secreted proteins-Vimentin, Galectin-1, Galectin-3 and ASC
and Thioredoxin.
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Table 2 Mass spectrometry results for autophagy-based unconventionally secreted
proteins

Protein Name

Protein Size

Score

10090 Gene_Symbol=H2afj Histone H2A.J

14 kDa

-2.5

10090 Gene_Symbol=Arpc5 Actin-related protein 2/3 complex subunit 5

16 kDa

-2.5

10090 Gene_Symbol=Hist2h2ab;Hist2h2ac Histone H2A type 2-C

14 kDa

-2.1

10090 Gene_Symbol=H2afz Histone H2A.Z

14 kDa

-1.7

10090
Gene_Symbol=Hist1h2bj;Hist1h2bl;Hist1h2bn;Hist1h2bf;LOC100046213
Histone H2B type 1-F/J/L
10090 Gene_Symbol=Lyz2 Lysozyme C-2

14 kDa

-0.9

18 kDa

-0.7

10090 Gene_Symbol=Ctsc Dipeptidyl-peptidase 1

52 kDa

-0.6

10090 Gene_Symbol=Lipa Lysosomal acid lipase/cholesteryl ester hydrolase

46 kDa

-0.6

10090 Gene_Symbol=Psap prosaposin isoform A preproprotein

61 kDa

-0.5

10090 Gene_Symbol=Ctsd Cathepsin D

45 kDa

-0.5

10090 Gene_Symbol=Hexa Beta-hexosaminidase subunit alpha

61 kDa

-0.5

10090 Gene_Symbol=Hnrnph2 Heterogeneous nuclear ribonucleoprotein H2

49 kDa

-0.5

10090 Gene_Symbol=Gm2a Ganglioside GM2 activator

21 kDa

-0.5

10090 Gene_Symbol=Gpnmb Transmembrane glycoprotein NMB

64 kDa

-0.4

10090 Gene_Symbol=Cfl1 Cofilin-1

19 kDa

-0.4

10090 Gene_Symbol=Fth1 Ferritin heavy chain

21 kDa

-0.4

10090 Gene_Symbol=Grn granulin

65 kDa

-0.4

10090 Gene_Symbol=Ctsb Cathepsin B

37 kDa

-0.4

10090 Gene_Symbol=Asah1 Acid ceramidase

45 kDa

-0.4

10090 Gene_Symbol=Tpd52 Isoform 2 of Tumor protein D52

20 kDa

-0.4

10090 Gene_Symbol=Ctsz Cathepsin Z

34 kDa

-0.4

10090 Gene_Symbol=Il1rn Isoform 1 of Interleukin-1 receptor antagonist
protein
10090 Gene_Symbol=Hexb Beta-hexosaminidase subunit beta

20 kDa

-0.4

61 kDa

-0.4

10090 Gene_Symbol=Cdc42 Isoform 2 of Cell division control protein 42
homolog
10090 Gene_Symbol=Creg1 Protein CREG1

21 kDa

-0.4

24 kDa

-0.4

10090 Gene_Symbol=Tgm2 Protein-glutamine gamma-glutamyltransferase 2 77 kDa

-0.4

10090 Gene_Symbol=Scpep1 serine carboxypeptidase 1

51 kDa

-0.4

10090 Gene_Symbol=Plek Pleckstrin

40 kDa

-0.4

10090 Gene_Symbol=Galns N-acetylgalactosamine-6-sulfatase

58 kDa

-0.4

10090 Gene_Symbol=Plbd2 Isoform 1 of Putative phospholipase B-like 2

66 kDa

-0.4

10090 Gene_Symbol=Dpp7 Dipeptidyl-peptidase 2

56 kDa

-0.4

10090 Gene_Symbol=Gnptab Gnptab protein

117 kDa

-0.4

10090 Gene_Symbol=Msn Moesin

68 kDa

-0.3

10090 Gene_Symbol=Glrx Glutaredoxin-1

12 kDa

-0.3
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10090 Gene_Symbol=Coro1a Coronin-1A

51 kDa

-0.3

10090 Gene_Symbol=Efhd2 EF-hand domain-containing protein D2

27 kDa

-0.3

10090 Gene_Symbol=Eef1a1 Elongation factor 1-alpha 1

50 kDa

-0.3

10090 Gene_Symbol=Naga Alpha-N-acetylgalactosaminidase

47 kDa

-0.3

10090 Gene_Symbol=Calm1;Calm3;Calm2 Putative uncharacterized protein

22 kDa

-0.3

10090 Gene_Symbol=Ehd4 EH-domain containing 4-KJR (Fragment)

62 kDa

-0.3

10090 Gene_Symbol=Arf2 ADP-ribosylation factor 2

21 kDa

-0.3

10090 Gene_Symbol=Pld4 Isoform 1 of Phospholipase D4

56 kDa

-0.3

10090 Gene_Symbol=Rpl12 60S ribosomal protein L12

18 kDa

-0.3

10090 Gene_Symbol=Gns N-acetylglucosamine-6-sulfatase

61 kDa

-0.3

10090 Gene_Symbol=Gm4735;Eno1;LOC100044223;Gm5506 Alphaenolase
10090 Gene_Symbol=Vim Vimentin

47 kDa

-0.2

54 kDa

-0.2

10090 Gene_Symbol=Tubb5 Tubulin beta-5 chain

50 kDa

-0.2

10090 Gene_Symbol=Tkt Transketolase

68 kDa

-0.2

10090 Gene_Symbol=Vcp Transitional endoplasmic reticulum ATPase

89 kDa

-0.2

10090 Gene_Symbol=Ppia Peptidyl-prolyl cis-trans isomerase

18 kDa

-0.2

10090 Gene_Symbol=Eef2 Elongation factor 2

95 kDa

-0.2

10090 Gene_Symbol=Pgk1 Phosphoglycerate kinase 1

45 kDa

-0.2

10090 Gene_Symbol=Gpi1 Glucose-6-phosphate isomerase

63 kDa

-0.2

10090 Gene_Symbol=Prdx5 Isoform Mitochondrial of Peroxiredoxin-5,
mitochondrial
10090 Gene_Symbol=Pfn1 Profilin-1

22 kDa

-0.2

15 kDa

-0.2

10090 Gene_Symbol=Aldoa Fructose-bisphosphate aldolase A

39 kDa

-0.2

10090 Gene_Symbol=Uba1 Ubiquitin-like modifier-activating enzyme 1

118 kDa

-0.2

10090 Gene_Symbol=Gusb Beta-glucuronidase

74 kDa

-0.2

10090 Gene_Symbol=Tln1 Talin-1

270 kDa

-0.2

10090 Gene_Symbol=Tpi1 triosephosphate isomerase 1

32 kDa

-0.2

10090 Gene_Symbol=Eif4a1 Eukaryotic initiation factor 4A-I

46 kDa

-0.2

10090 Gene_Symbol=Akr1b3 Aldose reductase

36 kDa

-0.2

10090 Gene_Symbol=Cd14 Monocyte differentiation antigen CD14

39 kDa

-0.2

10090 Gene_Symbol=Ostf1 Osteoclast-stimulating factor 1

24 kDa

-0.2

10090 Gene_Symbol=Sh3bgrl SH3 domain-binding glutamic acid-rich-like
protein
10090 Gene_Symbol=Gm8394 similar to zeta proteasome chain; PSMA5
isoform 2
10090 Gene_Symbol=Ctss Putative uncharacterized protein

13 kDa

-0.2

26 kDa

-0.2

39 kDa

-0.2

10090 Gene_Symbol=Rap1a Ras-related protein Rap-1A

21 kDa

-0.2

10090 Gene_Symbol=Uba52;2810422J05Rik;Gm11808 hypothetical protein
LOC666586
10090 Gene_Symbol=Ctsa Lysosomal protective protein

15 kDa

-0.2

54 kDa

-0.2

10090 Gene_Symbol=Hnrnpk Isoform 1 of Heterogeneous nuclear
ribonucleoprotein K
10090 Gene_Symbol=Ppp2r4 Serine/threonine-protein phosphatase 2A

51 kDa

-0.2

37 kDa

-0.2
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regulatory subunit B'
10090 Gene_Symbol=Tubb4 Tubulin beta-4 chain

50 kDa

-0.2

10090 Gene_Symbol=Rplp1 60S acidic ribosomal protein P1

11 kDa

-0.2

10090 Gene_Symbol=Grb2 Isoform 1 of Growth factor receptor-bound
protein 2
10090 Gene_Symbol=Gnb2l1 Guanine nucleotide-binding protein subunit
beta-2-like 1
10090 Gene_Symbol=Ppp1cc Isoform Gamma-1 of Serine/threonine-protein
phosphatase PP1-gamma catalytic subunit
10090 Gene_Symbol=Lamp1 Lysosomal membrane glycoprotein 1, isoform
CRA_a
10090 Gene_Symbol=Rpl18 60S ribosomal protein L18

25 kDa

-0.2

35 kDa

-0.2

37 kDa

-0.2

44 kDa

-0.2

22 kDa

-0.2

10090 Gene_Symbol=Twf2 Isoform 1 of Twinfilin-2

39 kDa

-0.2

10090 Gene_Symbol=Cct7 T-complex protein 1 subunit eta

60 kDa

-0.2

10090 Gene_Symbol=Actb Actin, cytoplasmic 1

42 kDa

-0.1

10090 Gene_Symbol=Ldha L-lactate dehydrogenase A chain

36 kDa

-0.1

10090 Gene_Symbol=Hspa8 Heat shock cognate 71 kDa protein

71 kDa

-0.1

10090 Gene_Symbol=Gdi2 Isoform 1 of Rab GDP dissociation inhibitor beta 51 kDa

-0.1

10090 Gene_Symbol=Cndp2 Cytosolic non-specific dipeptidase

53 kDa

-0.1

10090 Gene_Symbol=Fabp5 Fatty acid-binding protein, epidermal

15 kDa

-0.1

10090 Gene_Symbol=Lgals3 Galectin-3

28 kDa

-0.1

10090 Gene_Symbol=Pgam1 Phosphoglycerate mutase 1

29 kDa

-0.1

10090 Gene_Symbol=Tuba1b Tubulin alpha-1B chain

50 kDa

-0.1

10090 Gene_Symbol=Lgals1 Galectin-1

15 kDa

-0.1

10090 Gene_Symbol=Gm16374 similar to Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) isoform 1
10090 Gene_Symbol=Hsp90ab1 MCG18238

36 kDa

-0.1

83 kDa

-0.1

10090 Gene_Symbol=Actn4 Alpha-actinin-4

105 kDa

-0.1

UPSP:K1CI_HUMAN_contaminant KERATIN, TYPE I CYTOSKELETAL
9 (CYTOKERATIN 9) (K9) (CK 9)>PIR2:I
10090 Gene_Symbol=Cap1 Adenylyl cyclase-associated protein 1

62 kDa

-0.1

52 kDa

-0.1

10090 Gene_Symbol=Gbp2 Interferon-induced guanylate-binding protein 2

67 kDa

-0.1

10090 Gene_Symbol=Vat1 Synaptic vesicle membrane protein VAT-1
homolog
10090 Gene_Symbol=Wdr1 WD repeat-containing protein 1

43 kDa

-0.1

66 kDa

-0.1

10090 Gene_Symbol=Taldo1 Transaldolase

37 kDa

-0.1

10090 Gene_Symbol=Tagln2 Transgelin-2

22 kDa

-0.1

10090 Gene_Symbol=Nme2 Nucleoside diphosphate kinase B

17 kDa

-0.1

10090 Gene_Symbol=A2m Alpha-2-macroglobulin-P

164 kDa

-0.1

10090 Gene_Symbol=Eif5a Eukaryotic translation initiation factor 5A-1

17 kDa

-0.1

10090 Gene_Symbol=Psma2 Proteasome subunit alpha type

28 kDa

-0.1

10090 Gene_Symbol=Clic1 Chloride intracellular channel protein 1

27 kDa

-0.1

10090 Gene_Symbol=Tpt1;Gm14456 Translationally-controlled tumor
protein
10090 Gene_Symbol=Aprt adenine phosphoribosyltransferase

20 kDa

-0.1

20 kDa

-0.1
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10090 Gene_Symbol=Ywhab Isoform Long of 14-3-3 protein beta/alpha

28 kDa

-0.1

10090 Gene_Symbol=Myl6 Isoform Smooth muscle of Myosin light
polypeptide 6
10090 Gene_Symbol=Cmpk1 UMP-CMP kinase 1

17 kDa

-0.1

26 kDa

-0.1

10090 Gene_Symbol=Actc1 Actin, alpha cardiac muscle 1

42 kDa

-0.1

10090 Gene_Symbol=Hnrnpa2b1 Isoform 3 of Heterogeneous nuclear
ribonucleoproteins A2/B1
10090 Gene_Symbol=Txn1 Thioredoxin

32 kDa

-0.1

12 kDa

-0.1

10090 Gene_Symbol=Gm10079 Rps16 protein

19 kDa

-0.1

10090 Gene_Symbol=Gsn Isoform 1 of Gelsolin

86 kDa

-0.1

10090 Gene_Symbol=Samhd1 SAM domain and HD domain-containing
protein 1
10090 Gene_Symbol=Apob Apob protein (Fragment)

73 kDa

-0.1

165 kDa

-0.1

10090 Gene_Symbol=Hsp90aa1 Heat shock protein HSP 90-alpha

85 kDa

-0.1

10090 Gene_Symbol=Nme1;LOC100046344 Nucleoside diphosphate kinase
A
10090 Gene_Symbol=AW551984 Putative uncharacterized protein

17 kDa

-0.1

89 kDa

-0.1

10090 Gene_Symbol=Flna Isoform 1 of Filamin-A

281 kDa

-0.1

10090 Gene_Symbol=Fam129b Niban-like protein 1

85 kDa

-0.1

10090 Gene_Symbol=Ywhaq Isoform 1 of 14-3-3 protein theta

28 kDa

-0.1

10090 Gene_Symbol=Adssl1 Isoform 1 of Adenylosuccinate synthetase
isozyme 1
10090 Gene_Symbol=Kpnb1 Importin subunit beta-1

50 kDa

-0.1

97 kDa

-0.1

10090 Gene_Symbol=Gm9826;Ahcy Adenosylhomocysteinase

48 kDa

-0.1

10090 Gene_Symbol=Sars Seryl-aminoacyl-tRNA synthetase, isoform
CRA_b
10090 Gene_Symbol=Gmfb Glia maturation factor, beta

61 kDa

-0.1

17 kDa

-0.1

10090 Gene_Symbol=Pycard Apoptosis-associated speck-like protein
containing a CARD
10090 Gene_Symbol=Fam49b Protein FAM49B

21 kDa

-0.1

37 kDa

-0.1

10090 Gene_Symbol=Mtpn Myotrophin

13 kDa

-0.1

10090 Gene_Symbol=Psmb4 Proteasome subunit beta type-4

29 kDa

-0.1

10090 Gene_Symbol=Pgls 6-phosphogluconolactonase

27 kDa

-0.1

10090 Gene_Symbol=Ppp2r1a Serine/threonine-protein phosphatase 2A 65
kDa regulatory subunit A alpha isoform
10090 Gene_Symbol=mCG_122533;Rpsa 40S ribosomal protein SA

65 kDa

-0.1

33 kDa

-0.1

10090 Gene_Symbol=Fabp7 Fatty acid-binding protein, brain

15 kDa

-0.1

10090 Gene_Symbol=Pebp1 Phosphatidylethanolamine-binding protein 1

21 kDa

-0.1

10090 Gene_Symbol=LOC100044514;Gm10349;Nutf2;Gm10333 Nuclear
transport factor 2
10090 Gene_Symbol=Eef1g Elongation factor 1-gamma

14 kDa

-0.1

50 kDa

-0.1

10090 Gene_Symbol=Arpc1b Arpc1b protein

41 kDa

-0.1

10090 Gene_Symbol=Psma7 Proteasome subunit alpha type-7

28 kDa

-0.1

10090 Gene_Symbol=Stip1 Stress-induced-phosphoprotein 1

63 kDa

-0.1

10090 Gene_Symbol=Tubb2b Tubulin beta-2B chain

50 kDa

-0.1
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10090 Gene_Symbol=Ogn Mimecan

34 kDa

-0.1

10090 Gene_Symbol=Lasp1 LIM and SH3 domain protein 1

30 kDa

-0.1

10090 Gene_Symbol=Tbc1d8b TBC1 domain family member 8B

128 kDa

-0.1

10090 Gene_Symbol=Rab11b Ras-related protein Rab-11B

24 kDa

-0.1

10090 Gene_Symbol=Fermt3 Fermitin family homolog 3

76 kDa

-0.1

10090 Gene_Symbol=Anxa5 Annexin A5

36 kDa

-0.1

10090 Gene_Symbol=Pcbp1 Poly(rC)-binding protein 1

37 kDa

-0.1

10090 Gene_Symbol=LOC100044177;Ezr Ezrin

69 kDa

-0.1

10090 Gene_Symbol=Hspa4 Heat shock 70 kDa protein 4

94 kDa

-0.1

10090 Gene_Symbol=Pkm2 Isoform M2 of Pyruvate kinase isozymes M1/M2 58 kDa

0

10090 Gene_Symbol=Lcp1 Plastin-2

70 kDa

0

10090 Gene_Symbol=Serpinb6a Serpin B6

43 kDa

0

10090 Gene_Symbol=Actr3 Actin-related protein 3

47 kDa

0

10090 Gene_Symbol=Pnp1 Purine nucleoside phosphorylase

32 kDa

0

10090 Gene_Symbol=Hk3 Hexokinase-3

100 kDa

0

10090 Gene_Symbol=Cltc Clathrin heavy chain 1

192 kDa

0

10090 Gene_Symbol=Capg Putative uncharacterized protein

39 kDa

0

10090 Gene_Symbol=Atp6v1a Isoform 1 of V-type proton ATPase catalytic
subunit A
10090 Gene_Symbol=Idh1 Putative uncharacterized protein

68 kDa

0

48 kDa

0

10090 Gene_Symbol=Itih3 Inter-alpha-trypsin inhibitor heavy chain H3

99 kDa

0

10090 Gene_Symbol=Blvrb Flavin reductase

22 kDa

0

10090 Gene_Symbol=Ywhae 14-3-3 protein epsilon

29 kDa

0

10090 Gene_Symbol=Prdx2 Peroxiredoxin-2

22 kDa

0

10090 Gene_Symbol=Arpc2 Actin-related protein 2/3 complex subunit 2

34 kDa

0

10090 Gene_Symbol=Arhgdib Rho GDP-dissociation inhibitor 2

23 kDa

0

10090 Gene_Symbol=Clic4 Chloride intracellular channel protein 4

29 kDa

0

10090 Gene_Symbol=Stat1 Putative uncharacterized protein

88 kDa

0

10090 Gene_Symbol=Cotl1 Coactosin-like protein

16 kDa

0

10090 Gene_Symbol=Capza2 F-actin-capping protein subunit alpha-2

33 kDa

0

10090 Gene_Symbol=Sh3bgrl3 SH3 domain-binding glutamic acid-rich-like
protein 3
10090 Gene_Symbol=Tpm4 Tropomyosin alpha-4 chain

10 kDa

0

28 kDa

0

10090 Gene_Symbol=Sod1 Superoxide dismutase [Cu-Zn]

16 kDa

0

10090 Gene_Symbol=Rnh1 Ribonuclease inhibitor

50 kDa

0

10090 Gene_Symbol=Gm10145 similar to LOC446231 protein

18 kDa

0

10090 Gene_Symbol=Dbi diazepam binding inhibitor isoform 1

15 kDa

0

10090 Gene_Symbol=Pzp Alpha-2-macroglobulin

167 kDa

0

10090 Gene_Symbol=Mdh1 Malate dehydrogenase, cytoplasmic

37 kDa

0

10090 Gene_Symbol=Lum Lumican

38 kDa

0

10090 Gene_Symbol=Psmb3 Proteasome subunit beta type-3

23 kDa

0

10090 Gene_Symbol=Gdi1 Rab GDP dissociation inhibitor alpha

51 kDa

0
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10090 Gene_Symbol=Uap1l1 Isoform 1 of UDP-N-acetylhexosamine
pyrophosphorylase-like protein 1
10090 Gene_Symbol=Psmb1 Proteasome subunit beta type-1

57 kDa

0

26 kDa

0

10090 Gene_Symbol=Dpysl2 Dihydropyrimidinase-related protein 2

62 kDa

0

10090 Gene_Symbol=Cstb Cystatin-B

11 kDa

0

10090 Gene_Symbol=Lgals3bp Galectin-3-binding protein

64 kDa

0

10090 Gene_Symbol=Psmd12 Putative uncharacterized protein

53 kDa

0

10090 Gene_Symbol=Blvra Biliverdin reductase A

34 kDa

0

10090 Gene_Symbol=Ywhah 14-3-3 protein eta

28 kDa

0

10090 Gene_Symbol=Nampt Nicotinamide phosphoribosyltransferase

55 kDa

0

10090 Gene_Symbol=Kctd12 BTB/POZ domain-containing protein KCTD12 36 kDa

0

10090 Gene_Symbol=Pros1 Vitamin K-dependent protein S

75 kDa

0

10090 Gene_Symbol=Acat2 Acetyl-CoA acetyltransferase, cytosolic

41 kDa

0

10090 Gene_Symbol=Actn1 Alpha-actinin-1

103 kDa

0

10090 Gene_Symbol=Rab7 Ras-related protein Rab-7a

23 kDa

0

10090 Gene_Symbol=Nap1l4 Putative uncharacterized protein

47 kDa

0

10090 Gene_Symbol=Psma1 Proteasome subunit alpha type-1

30 kDa

0

10090 Gene_Symbol=LOC100045999;Ran GTP-binding nuclear protein Ran 24 kDa

0

10090 Gene_Symbol=Mapk1 Mitogen-activated protein kinase 1

41 kDa

0

10090 Gene_Symbol=Afm Isoform 3 of Afamin

70 kDa

0

10090 Gene_Symbol=Nagk N-acetyl-D-glucosamine kinase

37 kDa

0

10090 Gene_Symbol=Rps7 40S ribosomal protein S7

22 kDa

0

10090 Gene_Symbol=Col1a2 Collagen alpha-2(I) chain

130 kDa

0

10090 Gene_Symbol=Fkbp1a Peptidyl-prolyl cis-trans isomerase FKBP1A

12 kDa

0

10090 Gene_Symbol=Capzb Isoform 2 of F-actin-capping protein subunit
beta
10090 Gene_Symbol=Col1a1 Isoform 1 of Collagen alpha-1(I) chain

31 kDa

0

138 kDa

0

10090 Gene_Symbol=Vps26a Isoform 2 of Vacuolar protein sortingassociated protein 26A
10090 Gene_Symbol=Ptms Ptms protein

42 kDa

0

23 kDa

0

10090 Gene_Symbol=Prep Putative uncharacterized protein

83 kDa

0

10090 Gene_Symbol=Pgm2;Pgm1 Phosphoglucomutase-2

69 kDa

0

10090 Gene_Symbol=Cyp3a25 17 kDa protein

17 kDa

0

10090 Gene_Symbol=Rps19 40S ribosomal protein S19

16 kDa

0

10090 Gene_Symbol=Isyna1 Inositol-3-phosphate synthase 1

61 kDa

0

10090 Gene_Symbol=Alb Serum albumin

69 kDa

0.1

10090 Gene_Symbol=Ckb Creatine kinase B-type

43 kDa

0.1

10090 Gene_Symbol=Ywhag 14-3-3 protein gamma

28 kDa

0.1

10090 Gene_Symbol=Ifit3 Interferon-induced protein with tetratricopeptide
repeats 3
10090 Gene_Symbol=Ywhaz 14-3-3 protein zeta/delta

47 kDa

0.1

28 kDa

0.1

10090 Gene_Symbol=C3 Isoform Long of Complement C3 (Fragment)

186 kDa

0.1

10090 Gene_Symbol=Psme1 Proteasome activator complex subunit 1

29 kDa

0.1
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10090 Gene_Symbol=Esd S-formylglutathione hydrolase

31 kDa

0.1

10090 Gene_Symbol=Serpinf1 Pigment epithelium-derived factor

46 kDa

0.1

UPSP:TRYP_PIG_contaminant TRYPSIN PRECURSOR (EC
3.4.21.4)>PIR1:TRPGTR trypsin (EC 3.4.21.4) p
10090 Gene_Symbol=Psme2 Proteasome activator complex subunit 2

24 kDa

0.1

27 kDa

0.1

10090 Gene_Symbol=Actr2 Actin-related protein 2

45 kDa

0.1

10090 Gene_Symbol=S100a6 Protein S100-A6

10 kDa

0.1

10090 Gene_Symbol=Isg15 Ubiquitin cross-reactive protein

18 kDa

0.1

10090 Gene_Symbol=Tpm3 Isoform 2 of Tropomyosin alpha-3 chain

29 kDa

0.1

10090 Gene_Symbol=Iqgap1 Ras GTPase-activating-like protein IQGAP1

189 kDa

0.1

10090 Gene_Symbol=Arhgdia Rho GDP-dissociation inhibitor 1

23 kDa

0.1

10090 Gene_Symbol=Vcl Vinculin

117 kDa

0.1

10090 Gene_Symbol=Myh9 Myosin-9

226 kDa

0.1

10090 Gene_Symbol=Ipo5 Isoform 1 of Importin-5

124 kDa

0.1

10090 Gene_Symbol=Cct6a T-complex protein 1 subunit zeta

58 kDa

0.1

10090 Gene_Symbol=Hbb-b2 Hemoglobin subunit beta-2

16 kDa

0.1

10090 Gene_Symbol=Ftl2 Ferritin light chain 2

21 kDa

0.1

10090 Gene_Symbol=Gstm7 Glutathione S-transferase Mu 7

26 kDa

0.1

10090 Gene_Symbol=Ahsa1 Activator of 90 kDa heat shock protein ATPase
homolog 1
10090 Gene_Symbol=Gc Vitamin D-binding protein

38 kDa

0.1

54 kDa

0.1

10090 Gene_Symbol=Itih4 inter alpha-trypsin inhibitor, heavy chain 4
isoform 2
10090 Gene_Symbol=Psmb2 Proteasome subunit beta type-2

105 kDa

0.1

23 kDa

0.1

10090 Gene_Symbol=Cpn1 Carboxypeptidase N catalytic chain

52 kDa

0.1

10090 Gene_Symbol=Psma4 Proteasome subunit alpha type-4

29 kDa

0.1

10090 Gene_Symbol=Vps35 Vacuolar protein sorting-associated protein 35

92 kDa

0.1

10090 Gene_Symbol=Thbs4 Thrombospondin-4

106 kDa

0.1

10090 Gene_Symbol=Ugp2 Isoform 1 of UTP--glucose-1-phosphate
uridylyltransferase
10090 Gene_Symbol=Atp6v1h V-type proton ATPase subunit H

57 kDa

0.1

56 kDa

0.1

10090 Gene_Symbol=Cntn1 Contactin-1

113 kDa

0.1

10090 Gene_Symbol=Arpc3 Actin-related protein 2/3 complex subunit 3

21 kDa

0.1

10090 Gene_Symbol=Lta4h Leukotriene A-4 hydrolase

69 kDa

0.1

10090 Gene_Symbol=Cct2 T-complex protein 1 subunit beta

57 kDa

0.1

10090 Gene_Symbol=Pdia3 Protein disulfide-isomerase A3

57 kDa

0.1

10090 Gene_Symbol=Rbp4 Retinol-binding protein 4

23 kDa

0.1

10090 Gene_Symbol=Nap1l1 Nucleosome assembly protein 1-like 1

45 kDa

0.1

10090 Gene_Symbol=Npepps Puromycin-sensitive aminopeptidase

103 kDa

0.1

10090 Gene_Symbol=C4b Complement C4-B

193 kDa

0.1

10090 Gene_Symbol=Nt5c3 Isoform 2 of Cytosolic 5'-nucleotidase 3

37 kDa

0.1

10090 Gene_Symbol=Copg Putative uncharacterized protein

98 kDa

0.1

10090 Gene_Symbol=Capza1 F-actin-capping protein subunit alpha-1

33 kDa

0.1
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10090 Gene_Symbol=Vbp1 Prefoldin subunit 3

22 kDa

0.1

10090 Gene_Symbol=Pgm2;Pgm1 Phosphoglucomutase-1

62 kDa

0.1

10090 Gene_Symbol=Akr1a4 Alcohol dehydrogenase [NADP+]

37 kDa

0.2

10090 Gene_Symbol=Pgd 6-phosphogluconate dehydrogenase,
decarboxylating
10090 Gene_Symbol=Itih2 inter-alpha trypsin inhibitor, heavy chain 2

53 kDa

0.2

106 kDa

0.2

10090 Gene_Symbol=Pdxk Pyridoxal kinase

35 kDa

0.2

10090 Gene_Symbol=Cmpk2 UMP-CMP kinase 2, mitochondrial

50 kDa

0.2

10090 Gene_Symbol=Prdx6 Peroxiredoxin-6

25 kDa

0.2

10090 Gene_Symbol=G6pdx Glucose-6-phosphate 1-dehydrogenase X

59 kDa

0.2

10090 Gene_Symbol=Serpinc1 Antithrombin-III

52 kDa

0.2

10090 Gene_Symbol=Atp6v1e1 V-type proton ATPase subunit E 1

26 kDa

0.2

10090 Gene_Symbol=Anxa1 Annexin A1

39 kDa

0.2

10090 Gene_Symbol=Ifit2 Interferon-induced protein with tetratricopeptide
55 kDa
repeats 2
10090 Gene_Symbol=Vps29 Isoform 1 of Vacuolar protein sorting-associated 20 kDa
protein 29
10090 Gene_Symbol=Usp5 Ubiquitin carboxyl-terminal hydrolase 5
96 kDa

0.2

10090 Gene_Symbol=Mdh2 Malate dehydrogenase, mitochondrial

36 kDa

0.2

10090 Gene_Symbol=Apoa1 Apolipoprotein A-I

31 kDa

0.2

10090 Gene_Symbol=Nedd8 NEDD8

9 kDa

0.2

10090 Gene_Symbol=Kng1 Isoform HMW of Kininogen-1

73 kDa

0.2

10090 Gene_Symbol=Hyi Putative hydroxypyruvate isomerase

30 kDa

0.2

10090 Gene_Symbol=Fabp4 Fatty acid-binding protein, adipocyte

15 kDa

0.2

10090 Gene_Symbol=Aldh16a1 Aldehyde dehydrogenase family 16 member 85 kDa
A1
10090 Gene_Symbol=Hsbp1 Heat shock factor-binding protein 1
9 kDa

0.2

10090 Gene_Symbol=Psmb7 Proteasome subunit beta type-7

30 kDa

0.2

10090 Gene_Symbol=Tpp2 Isoform Short of Tripeptidyl-peptidase 2

138 kDa

0.2

10090 Gene_Symbol=Col6a1 Collagen alpha-1(VI) chain

108 kDa

0.2

10090 Gene_Symbol=Dcxr L-xylulose reductase

26 kDa

0.2

10090 Gene_Symbol=Nsf Vesicle-fusing ATPase

83 kDa

0.2

10090 Gene_Symbol=Wars Isoform 1 of Tryptophanyl-tRNA synthetase,
cytoplasmic
10090 Gene_Symbol=Psma6 Proteasome subunit alpha type-6

54 kDa

0.2

27 kDa

0.2

10090 Gene_Symbol=Pfkl phosphofructokinase, liver, B-type

85 kDa

0.2

10090 Gene_Symbol=Itih1 Itih1 protein

102 kDa

0.3

10090 Gene_Symbol=Hba-a2;Hba-a1 Putative uncharacterized protein

15 kDa

0.3

10090 Gene_Symbol=Cand1 Cullin-associated NEDD8-dissociated protein 1

136 kDa

0.3

10090 Gene_Symbol=Psmc6 26S protease regulatory subunit S10B

44 kDa

0.3

10090 Gene_Symbol=Commd5 COMM domain-containing protein 5

24 kDa

0.3

10090 Gene_Symbol=Pitpna Phosphatidylinositol transfer protein alpha
isoform
10090 Gene_Symbol=Prdx1 Peroxiredoxin-1

32 kDa

0.3

22 kDa

0.4
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0.2
0.2

0.2

10090 Gene_Symbol=S100a11 Protein S100-A11

11 kDa

0.4

10090 Gene_Symbol=Psmd13 Isoform 1 of 26S proteasome non-ATPase
regulatory subunit 13
10090 Gene_Symbol=Tubb3 Tubulin beta-3 chain

43 kDa

0.4

50 kDa

0.4

10090 Gene_Symbol=Myo18a Isoform 2 of Myosin-XVIIIa

196 kDa

0.4

10090 Gene_Symbol=Psmd6 26S proteasome non-ATPase regulatory subunit 46 kDa
6
10090 Gene_Symbol=Rps10 40S ribosomal protein S10
19 kDa

0.5

10090 Gene_Symbol=Tubb2c Tubulin beta-2C chain

50 kDa

Identified Proteins (307)

Molecular
Weight

No
Values
Quant 2
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0.5

GLOSSARY
ABC transporter: transmembrane proteins using ATP hydrolysis to translocates various
substrates across membranes
AcbA (Acb1): Acyl-CoA binding protein, required for differentiation of pre-spore cells
Atg5fl/fl LysM-Cre+: Mice deficient of Atg5 in myeloid lineage cells
Atg proteins: Autophagy related proteins
Bafilomycin A1: A specific inhibitor of vacuolar type H+-ATPase (V-ATPase), also
blocks autophagosome maturation
BMMs: bone marrow-derived macrophages
Caspase-1: Interleukin-1 converting enzyme, that proteolytically cleaves the precursor
forms of the inflammatory cytokines IL-1β and IL-18 into active mature
peptides
Cathepsin D: a ubiquitously expressed lysosomal aspartyl protease involved in the
normal degradation of proteins
Cathepsin K: a cystine protease involved in bone resorption
CFTR: Cystic Fibrosis Transmembrane conductance Regulator
COPII: coat protein complex II
CUPS: Compartment for Unconventional Protein Secretion
DAMPs: Damage Associated Molecular Patterns
DFCP1: Double FYVE-containing protein 1, the FYVE domain mediates the recruitment
of proteins involved in membrane trafficking and cell signaling to
phosphatidylinositol 3-phosphate (PtdIns(3)P)-containing membranes
ESCRT: Endosomal Sorting Complex Required for Transport
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FGF2: Fibroblast Growth Factor 2
GABARAP: γ-aminobutyric acid receptor-associated protein
Galectins: a family of proteins defined by their binding specificity for
β-galactoside sugars
GAP: GTPase- Activating Proteins
GEF: Guanine-nucleotide Exchange Factors
GATE-16 (GABARAPL2) : Golgi-associated ATPase enhancer of 16 kDa
GRASP55: Golgi Reassembly And Stacking Protein 55
GrpA: Golgi-associated protein GRASP
Grh1: Grasp homology 1
IL-1: Interleukin-1
LC3: light-chain 3, mammalian homologue of Atg8
MVB: MultiVesicular Body
NF-κB: nuclear factor kappa B
Nrf2: NF-E2 related factor 2
PAMPs: Pathogen Associated Molecular Patterns
P2X7 receptors: cation-permeable ligand gated ion channels that open in response to the
binding of extracellular ATP
Rab8a: a GTPase required for polarized membrane trafficking, constitutive biosynthetic
trafficking, and plasma membrane fusion of insulin-responsive and other
vesicular carriers
RIG-I: retinoic acid-inducible gene 1
SNARE: soluble NSF-attachment protein receptor
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Sso1: plasma membrane specific t-SNARE
Tlg2: endosomal t-SNARE which regulates membrane traffic through the yeast endocytic
system
TLR: Toll-like receptor
ULK1: Unc-51-like kinase 1
Vamp7: vesicle-associated membrane protein7
Vps4: an ATPase responsible for ESCRT-III disassembly and required for MVB protein
sorting
Vps23: a component of the ESCRT-I complex involved in ubiquitin-dependent sorting of
proteins into the MVB sorting pathway
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